Widanga (Embelia ribes)
Widanga (Embelia ribes)
Widanga (Embelia ribes Burm f) is one of the oldest herbs used as medicine world-wide. Sushruta the father of surgery identified many varieties of Widanga (species of Embelia) and described their stomachic, carminative, anthelmintic and alterative properties. Later Dr. Harris found in ancient Arabian writing, Widanga, (birang-I-kabauli in Arabic) being used as a remedy for tapeworm (The Lancet July 23, 1887). Tribal societies knew that Widanga (Embelia ribes) inhibits the process of implantation of embryo in the uterus. It was originally described in detail by Nicolas Laurens Burman in his publication: Flora Indica in 1768.
Widanga (Embelia ribes) is described as a powerful anthelmintic (Krimighna) in classical Ayurvedic texts "Charaka Samhitaa" and “Sushruta Samhitaa'. Modern world has validated the medicinal properties of Widanga described in Aayurvedic scriptures.
However, the dried fruit of Widanga (Embelia ribes) was officially declared and accepted as the botanical source of 'drug' by the Govt. of India in 1966 and was included in Indian Pharmacopoeia.
Widanga (Embelia ribes) is used in 75 Aayurvedic formulations. It is now an endangered, ‘Red listed’ species because of over-harvesting for medicinal purpose. Concerned about this Widanga (Embelia ribes) is listed in the ‘Priority Species List’ for cultivation by the National Medicinal Plant Board, India and the Maharashtra State Horticulture and Medicinal Plant Board, India. The Medicinal Board, Govt. of India, New Delhi has undertaken a project for large-scale cultivation of Widanga (Embelia ribes). Unfortunately, traditional methods of propagation are not successful in the large-scale production of this species and artificial regeneration of this species is difficult due to poor seed viability. Lack of knowledge about its distribution, poor natural regeneration and unknown propagation techniques have resulted in the lack of availability of ‘Quality Planting Material’ for promoting cultivation. Misidentification of the species Embelia ribes coupled with the use of adulterants and substitutes have further worsened the problem. , , , , 
Botanical: Embelia ribes Burm
Sanskrit: Tandula, Vella, Jantughna, Krimighna. Krimihara, Krimiripu
English: False Black Pepper
Gujarati : Waawadinga, Waayawadanga
Kannada: Waayuwidanga, Waayuwilanga
Malayalam: Wizalaari, Wizhalaari
Oriya: Widanga, Bidanga
Punjabi : Waawaringa, Baabrunga
Tamil : Waayuwidangam, Waayuwilangam
Telugu : Waayuwidangalu
Urdu: Baobarang, Babrang 
Family: Myrsinaceae 
Widanga (Embelia ribes Burm), a climber, is an Indo-Malaysian species, reported from India, Sri Lanka, Singapore and South China. It is found in places up to the height of 5000 feet (1500 meters). In India it occurs in Central and lower Himalayas, Arunachal Pradesh, Assam, Maharashtra, Andhra Pradesh, Karnataka, Kerala and Tamil Nadu. It is sparsely distributed in the evergreen to moist deciduous forests of the Western Ghats. It is distributed globally up to an altitude of 5000 feet (1500 meters). The species Embelia ribes Burm grows in semi-evergreen and deciduous forests throughout India. It ranges from India to Southern China, South to Indonesia, East Africa and on Malayan estates , 
Widanga (Embelia ribes) Plant
Widanga (Embelia ribes) Burm. f. plant is a large, scadent (climbing) flexible, dioecious, woody shrub; branches long, slender, terete with long internodes. The bark is studded with lenticels.
(Note: dioecious = having the male and female reproductive organs in separate flowers on separate plants)
Root: brownish grey hairy; rootlets reddish, hairy
Widanga (Embelia ribes) Stem
Stem: whitish grey, girth 45-72 cms when mature. The bark is studded with lenticels.
Widanga (Embelia ribes) Leaves
Leaves: simple, coriaceous (like leather in texture), 6-14 cm long and 2-4 cm broad, alternate, elliptic (ovate) or lanceolate, shortly and obtusely acuminate, entire, entire, perfectly glabrous on both sides, shining above, paler and somewhat silvery beneath, smooth; the whole surface covered with scattered minute reddish sunken gland (conspicuous in the young leaves), base rounded or acute; main nerves numerous, slender; petioles 0.8 to 1 cm long, more or less margined (having a distinct margin or border) glabrous; midrib prominent.
Widanga (Embelia ribes) Flower
Flowers: numerous, small, pentamerous (having five parts), globular, greenish yellow to whitish pink, in lax panicled (a much-branched inflorescence) racemes which are terminal and form the upper axils (the upper angle between a branch and the stem or trunk); branches of the panicle often 7.5-10 cm long with more or less glandular, pubescent; bracts (bract= a modified leaf) minute, setaceous (bristle like, having bristles), deciduous; Calyx is about 1.25 mm. long; sepals connate (united so as to form a single part), about 1/3rd of the way up, the teeth 5, broadly triangular-ovate, ciliated (having tiny hair-like projections); Petals 5, greenish yellow, free, 4 mm. long, elliptic, subobtuse (partially obtuse), and pubescent (covered with soft small hair, downy) on both sides; Stamens 5, shorter than the petals, erect; filaments inserted a little below the middle of the petals.
Widanga (Embelia ribes) Fruits
Fruit: small, oval shaped drupaceous berry, smooth, succulent, 3-4 mm in diameter found in bunches, varying in color from grey to red, reddish brown to brown black when unripe, black when ripe, like a peppercorn when dried, having a small beak-like projection, tipped with the persistent remains of style at the apex, outer rind fragile, wrinkled or warty when dry. In some fruits the pedicel (a small stalk bearing an individual flower in an inflorescence) along with persistent calyx is present. The flowers are polygamous. The fruits have a faint spicy odor and a pungent and astringent taste.
Widanga (Embelia ribes) Seeds
Seeds: Each fruit possesses a single seed which occupies the major portion of the fruit. The seed is enclosed by the stony endocarp. The seed is circular in shape, of reddish or brownish black in color speckled with yellowish brown or white spots; with a small beak at the apex. Most of the seeds are striate. The seeds are aromatic and slightly astringent pungent in taste. , , , 
Different Varieties: At present Embelia Tsjeriam -Cottom-R et S, Embelia robusta are supplied as Widanga (Embelia ribes) in India, but taxonomically they are not Widanga (Embelia ribes). P. V. Sharmaji reported that Myrsine africana Linn is sold as Widnga (Embelia ribes) but it is NOT Widanga (Embelia ribes), it is an adulterant.
True Widanga (Embelia ribes)
Embelia Tsjerian- Cottom- R et S (Adulterant)
Embelia robusta (Adulterant)
Myrsine africana (Adulterant)
Cross section of the seed measures about 1258.3 µm in length and 1167.9 µm in diameter, circular in outline, depression at the base exhibiting 3-4 inward intrusion of the perisperm. The seed is albuminous and trizonate, composed of seed coat, endosperm and embryo. The seed coat is distinctively multi-layered. Below the integument a few cell layers of nucellus (the central part of the ovule containing the embryo sac) are compressed and seeds with irregular tegmen (inner layer of seed coat) producing invagination inwards which protrudes into endosperm. The endosperm occupies the major portion of the seed and consists of several layers of cells with dense cytoplasm. The endosperm appears to be of labyrinthine type, composed of a network of lobules.
Embryo: small lies at the center of the seed, 724.9 µm in diameter, somewhat straight and embedded by the nutritive tissues of endosperm.
The mature root in transverse section is circular in outline with single layered epidermis. The epidermis possesses multi-cellular and uni-cellular glandular trichomes (a small hair or other outgrowth from epidermis); cork having 15-17 layers and schizogenous cavities (an inter-cellular space formed by splitting of the walls of adjacent cells). The cork is followed by a wavy sclerenchymatous ring. Beneath this, are seen secondary vascular tissues. Biseriate (having two layers) medullary rays with tannin cells are very conspicuous.
Mature stem in transverse section appears somewhat circular in outline. The epidermis single layered with unicellular gladular trichomes; Periderm 5-6 layered followed by distinguishable cortical region of parenchymatous and sclerenchymatous tissue. Tannin cells are prominent in parenchymatous region (in phloem tissue). Schizogenous cavities are conspicuous. Schizogenous strand arches into the secondary phloem tissue. The secondary xylem and secondary phloem are produced by cambium. The vessels have large lumen. Medullary rays are thin walled and biseriate. Pith cells are parenchymatous.
The transverse section shows common dicotyledonous characters. The epidermis single layered without trichomes; Mesophyll consists of a single layered palisade, spongy tissue with abundant intercellular spaces. The cells of mesophyll are rich tannin and oil glands. The vascular bundle 'C' shaped, broad; phloem fibers very prominent; stomata of Ranunculaceous type.
In transverse section the petiole appears shield shaped in outline; vascular bundle crescent shaped; epidermis single layered; cuticle thin, cortical region parenchymatous; schezogenous cavities few; tannin cells are very common.
In mature fruits, the transverse section shows the pericarp possessed a thin epicarp, a more or less fleshy parenchymatous mesocarp and stony endocarp. The epidermis of the epicarp usually obliterated in surface view, consists of a single continuous layer of rectangular cells, covered by the thick wrinkled cuticle which is thinned towards the end of fruit development because of undergoing accentuated reduction in thickness which can in part be the result of rapidly expansion of pericarp. The mesocarp consists of a number of reddish-brown colored scattered patches of brachysclerides and numerous fibrovascular bundles and rarely a few prismatic crystals of calcium oxalate, oil bodies and abundant starch grains may also be found. Inner part of mesocarp and endodermis composed of stone cells. Endocarp is composed of several internal layers of brachysclerides arranged in a pyramidal fashion. The cells are irregular shape, thick-walled. The thickness of stony endocarp is 99.9 µm to 100.2 µm. The cells contain fixed oil and proteinous masses. Extensive lignifications of the endocarp provide it as the main protective layer of pericarp. The typical drupes frequently possess sclerified endocarps. Such drupes considered to be highly specialized fruits, are provided with several secretory structures.
Small when present otherwise most of the seeds are sterile.
Reddish in color.The microscopic examination of the powder shows:
----Reddish brown parenchyma
----Stone cells and sclerides of the mesocarp
----Epicarp in the surface view with striated cuticle
----Dark brown-colored cells of perisperm
----Cells of endosperm filled with aleurone (a protein found in protein granules of maturing seeds) grains and fixed oil
----Dark brown-colored palisade like cells of the endocarp , , , , 
Several chemicals found in berries of Widanga (Embelia ribes) are:
Christembine, potassium embelate, rapanone, embelic acid, caffeic acid, vanillic acid, chlorogenic acid, cinnamic acid, o-cumaric acid, volatile oil, resin, tannin, embelin, flavonoid quercetin, benzoquinone, fatty ingredients and vilangin, sitosterol and daucosterol.
Some new compounds identified in seeds are: embelinol, embeliaribyl ester, embeliol and a known compound embelin. 
Identity, Purity and Strength:
(1) To 20 ml of solvent ether, add 1 g of powdered seeds of Widanga (Embelia ribes), shake for 5 minutes, filter. To a portion (10 ml) of the filtrate add slowly 5% v/v solution of NaOH (sodium hydroxide), a deep violate color develops in the aqueous portion. To the other portion add 2 drops of dilute ammonia (NH4OH) solution, a bluish violate precipitate is obtained.
(2) To 25 ml of alcohol, add 5 g of powdered seeds of Widanga (Embelia ribes), boil, filter, a deep red colored filtrate is obtained. Divide into two portions. To one add lead acetate [Pb(CH3COO)2] solution, a dirty green precipitate is obtained. To the other portion, add ferric chloride (FeCl 3] solution, a reddish-brown precipitate is obtained. 
TLC Finger printing Profile of Stem:
Researchers observed prominent bands with anisaldehyde spray and sulphuric acid spray at the Rf values 0.13, o.33, 0.54, 0.97 and 0.37, 0.55 and 0.98 respectively
TLC Finger printing profile of leaf:
Researchers observed several bands with anisaldehyde spray and long UV and Chlorophyll content is major contributor for the banding pattern.
TLC Finger printing profile of Fruit:
Researchers observed prominent bands with anisaldehyde spray and sulphuric acid spray at the Rf values 0.27, 0.91 and 0.32, 0.51, 0.56 respectively. One band is visible under long UV and short UV.
In one study the fruits of Widanga (Embelia ribes) when extracted in 100 % methanol for 30 minutes yielded 14.9 mg/gm dry weight of Embelin, a new anticancer agent. , 
Sift 10 g of Widanga (Embelia ribes) powder through 40 mesh sieve. Transfer to 500 ml stoppered glass conical flask. Shaking intermittently mix it with 150 ml of solvent ether, pack the whole mass in a percolator, allow to macerate for 30 minutes, extract the solvent ether till the ethereal solution ceases to give a pink color with a drop of dilute ammonia solution. Distil off the ether, treat the residue with small quantity of light petroleum, cool in ice, filter through a Buchner funnel under suction and reject the filtrate. Wash the Wash the residue further with small quantities of cooled ether. Transfer the residue to a tared beaker (previously weighed beaker) with sufficient quantity of solvent ether, remove the petroleum, dry the residue of embelin. The residue contains not less than 2% w/w of embelin (limit 1.85 to 2.15) 
For number of years there was controversy regarding the 'chromosomal identity' of Widanga (Embelia ribes). Now researchers are in agreement that number of chromosomes in Widanga (Embelia ribes) 2n=16. This number agrees with all previous chromosome numbers reported in the literature. 
By using RAPD-PCR and SCAR markers the researchers established an accurate genetic identity of Widanga (Embelia ribes). 28], 
Foreign matter NOT more than 2 percent
Total ash NOT more than 6 percent
Acid-insoluble ash NOT more than 1.5 percent
Alcohol-soluble extractive NOT less than 10 percent
Water-soluble extractive NOT less than 9 percent
The ether extract of Widanga (Embelia ribes) contains not less than 2 percent w/w of embelin (range 1.85-2.15) 
The international guidelines for acceptable microbial limits in herbal formulations are:
Total bacterial count: Not more than 105cfu/g
Total yeast and mould count: Not more than 104cfu/g
Bile tolerant gram negative bacteria: Not more than 104cfu/g
Salmonella spp: Absent in 25 g
Escherichia coli: Absent in 1g
Staphylococcus aureus: Absent in 1g
Pseudomonas aeruginosa: Absent in 1g
Arsenic: Not more than 5.0 mg/kg
Mercury: Not more than 0.5mg/kg
Lead: Not more than 10.0 mg/kg
Chromium: Not more than 0.3 mg/kg
The determination of physicochemical parameters is important in determination of adulterants and improper handling of drugs. The following table shows physicochemical parameters of powder of the fruit of Widanga (Embelia ribes)
SD (Standard Deviation)
SE (Standard Error)
% RSD (Relative Standard Deviation
Acid insoluble ash
Ethanol Extractable matter
Loss on drying (100-1050C)
<100 nbsp="" o:p="">100>
Ash values are used to determine quality and purity of crude drugs. Ash values indicate the presence of various impurities like carbonate, oxalate, silicate etc. The acid insoluble ash consists mainly of silica that indicates contamination with earthy material. The water soluble ash indicates the presence of inorganic elements in drugs. The following table indicates ash values for powder of the fruit of Widanga (Embelia ribes)
SE ((Standard Error)
% RSD (Relative Standard Deviation)
Water soluble ash
Water extractable matter
Properties and Pharmacology:
Ganas: (Classical Catagories)
Charaka+ Ganas- Warga: Krimighna, Kushthaghna
Sushruta+Ganas- Warga: Surasaadi, Pippalyaadi
Ashtaanga Sangraha+ Ganas-Warga: Surasaadi, Pippalyaadi , 
Rasa (Taste): Katu (Acrid, Pungent, Piquant), Tikta (Bitter), Kashaya (Astringent)
Weerya/ Virya (Energy State): Ushna (Hot)
Wipaaka/ Vipak (End result, Post digestive effect): Katu (Acrid)
Prabhaawa/Prabhav (Special Effect, Prominent Effect): Krimighna (Anthelmintic)
Note: Here I wish to clarify the meaning of these technical words:
Virya (Weerya): Potency, power, vigor
Vipak (Wipaak): After digestion change of taste. The food we take is acted upon by jaatharagni (digestive activity, digestive juices) and the taste of the food changes. The original rasa (taste) changes to vipak (new or same taste.)
Prabhav (Prabhaawa): Effect, prominent, peculiar or special action of an herb. Innate and specific property
Gunas (Qualities): Laghu (light), Rooksha (dry), Teekshna (penetrating)
Effects on Doshas: Waata, Kapha
Actions on Dhaatus (Tissues): Rasa (lymph), Rakta (Blood), Meda (Fat), Shukra (Semen)
Actions on Srotas (Systems): Pureeshwaha (Colorectal region), Rasawaha (Lymphatic syatem), Raktawaha (Hematopoetic system) Mootrawaha (Urinary system), Shukrawaha (Genital system) 
Ayurvedic Actions (Karma):
Deepana/ Wahnikara/ Agnimaandyahara: Appetizer, relieves indigestion
Aruchihara: Relieves anorexia
Shoolahara: Relieves abdominal pain
Aadhmaanahara: Relieves abdominal bloating
Waatahara: Useful in abdominal flatulence
Anulomana: Prokinetic, Carminative
Anulomana: Prokinetic, Carminative
Wibandhanut: Relieves constipation
Udarahara: Relieves ascites
Krimikushtha: Useful in skin infections
Shleshma-krimihara: Useful for worm infestation of Kapha origin
Shirorogahara: Relieves headache
Wibhraatihara: Releaves gidiness, dizziness, vertigo
Raktashodhaka: Purifies blood, Anti-anemia
Rasaayana: Rejuvenative, Adaptogenic
Warnya: Beneficial for complexion
Pramehahara: Antidabetic , , 
Important References from Ayurvedic Texts
Widangam krimighnaanaam (shreshtham): Widanga is anthelmintic par excellencs (Charak Samhitaa; SootraSthaana 25)
Katu: (Acrid, Pungent, Piquant)
Kushthaghna: Anti-leprotic and Anti-infective for skin disorders
Pramehahara: Anti-diabetic, Reduces polyuria
Shirorogahara: Alleviates headache (Sushrut Samhitaa; Sootrasthaana 45)
Wibhramahara: Alleviates dementia, confusion, Alleviates vertigo
Udarahara: Relieves ascites
Wibandhahara: Relieves constipation 
Widanga (Embelia ribes) is anti-inflammatory, antibacterial, febrifuge, anthelmintic, carminative, astringent and hypotensive.
Pulp is purgative.
Fresh juice is laxative and diuretic.
The aqueous extract of the fruit is anthelmintic especially against tapeworms. The root acts as anti-diarrheal. The seeds are spermicidal, oxitocic and diuretic.
The whole plant shows blood purifying properties. The active principles found in the plant show estrogenic and progestogenic activity. 
Widanga (Embelia ribes) shows anti-inflammatory, anti-oxidant, antibacterial, anthelmintic, hypoglycemic, cardioprotective, antifertility and anti-tumor activity.
Widanga-fruits are used for the treatment of bronchitis, mental disorders, cardiovascular disorders, diabetes and jaundice; roots for influenza; seeds for tuberculosis and leaves for leprosy and many skin disorders. , 
Molecular formula: C17H26O4
Other Names: Embelin is also known as emberine, embelic acid, potassium embelate benzoquinone and many more.
Embelin is found to be located on the outer coat of seed beneath a thin membranous film, below the pericarp of the fruit.
Embelin occurs as golden yellow needles sparingly soluble in water but soluble in alcohol, chloroform and benzene. It is used to color silk and wool.
Sublimation and volatility are major characteristics of Embelin. It does not decompose under normal pressure after being heated. It can be distilled with water vapor which makes it easy to be extracted and purified.
Due to poor water solubility, bioavailability of embelin is erratic. That is why its clinical applications have limitations. On the other hand, its long alkyl chain (undecyl) provides it with long lipophilic ability and high cell membrane permeability which make it more stable and allow it enter the cells easily.
When irradiated with light of appropriate wave length, embelin can be activated to produce anti-inflammatory, anti-oxidant and anti-tumor effects. , , , 
Recently embelin has been synthesized in the laboratory. It will be of great advantage for new drug development 
Phytopharmacology of Embelin:
In an experimental study, embelin, a plant based benzoquinone derivative, shows an appreciable anti-inflammatory and analgesic activity 
In a study embelin was condensed with various primary amines to yield ten new derivatives along with monomethyl embelin. All these compounds and embelin, at 10 and 20 mg/kg body weight showed anti-inflammatory and analgesic activities. Embelin and two of its derivatives almost completely abolished the acetic acid induced writhing. However p-Sulfonylamine phenylamino derivative of embelin showed better anti-inflammatory activity than embelin. 
TNF- α is a pro-inflammatory chemical. TNF- α is synthesized as a membrane anchored protein (pro-TNF- α). A protease enzyme called TNF- α converting enzyme converts pro-TNF- α into a soluble form that is released into the extracellular space. This soluble form is responsible for the development of inflammation. By blocking this cascade, Embelin found in fruits of Widanga (Embelia ribes) acts as a natural anti-inflammatory agent. 
In an experimental study embelin was found to scavenge DPPH (2, 2-diphenyl-1 picrylhydrazyl) radicals. It inhibited hydroxyl radical induced lipid peroxidation and restored impaired manganese superoxide dismutase in mitochondria of the hepatocytes in rats. Using nanosecond pulse radiolysis technique suggests that embelin can act as a competitive antioxidant in physiological conditions.[ 50], 
Using different antioxidant tests, free radical scavenging activity and lipid peroxidation in albino rats, a group of researchers evaluated the antioxidant activity of embelin. By this study they concluded that embelin has a very potent antioxidant property. 
The principal phytochemical in the ethanol extract of Widanga (Embelia ribes) is embelin. At concentration of 100 mg/disc embelin showed antibacterial activity against Staphylococcus aureus, Shigella flexneri and Shigella sonnei. This activity was superior to kanamycin at 39 mg/ disc. Same kind of response was observed when embelin was used at 100 mg/disc against Pseudomonas aeruginosa at which it was superior to ciprofloxacin at 5 mg/disc. Embelin also shows strong antibacterial activity against Streptococcus pyogenes, Salmonella typhi, Shiegella boydii, Proteus mirabilis and mild antibacterial activity against Streptococcuc fecalis and Vibrio cholera. Methanol and aqueous extracts of the plant show moderate activity against multi-drug resistant Salmonella typhi.
In summary it can be said that embelin show good antibacterial activity against gram +ve and gram -ve organisms depending on the dose.
, , , , .
In another study, researchers isolated embelin in pure form from Widanga (Embelia ribes). By using disc diffusion they found that pure embelin had strong antibacterial activity against Streptococcus mitis and Bacillus subtilis, weak antibacterial activity against Staphylococcus aureus and no antibacterial activity against Escherichia coli.
The researchers are of the opinion that embelin is not a very efficient antibacterial compound but could give rise to more potent bioactive molecules by biotransformation. 
In Ayurveda Widanga (Embelia ribes Burm. f.) is famous for antimicrobial activity. However another species of Widanga is also used for antimicrobial activity. Taxonomically it is Embeliaro busta auct. Nonroxb. Therefore though this other species shows antimicrobial activity similar to that of Widanga (Embelia ribes Burm. f.); scientifically the other species is an adulterant. Researchers have proved Widanga (Embelia ribes Burm. f.) has more potent antimicrobial activity than the adulterant species Embeliaro busta auct. Nonroxb.
Hence the importance of chromosomal and genetic identification of herbs for effective pharmacological actions. 
The chemists developed semi-synthetic derivatives of embelin. The scientists compared the antibacterial and anti-fungal activities of these two compounds against 21 bacterial and 4 fungal pathogens. Both the compounds showed broad spectrum antibacterial activity against gram positive and gram negative bacteria at a concentration of 200 µg/ml. Among the tested bacteria some strains of Escherichia coli, Salmonella typhi, Staphylococcus aureus and Vibreo chloera were found to be highly susceptible to the tested compounds with activity ranging between 75 and 94% of that of that of ciprofloxacin. Similarly the tested compounds showed anti-fungal activity against four pathogenic fungi. Their antifungal activity was compared with that of griseofulvin. 
Recently a series of dihydropyran and dihydropyridin derivatives of embelin were synthesized. The obtained compounds showed antibacterial activity against Gram positive and Gram negative bacteria; more significantly against multi-drug-resistant Staphylococcus aureus. 
Using standard in vitro anti-fungal susceptibility methods, researchers found that embelin shows anti-fungal activity against Candida albicans, Candida tropicalis, Candida parapsilosis, Candida alidus and A. flavus 
By employing various concentrations of the extract of seeds of Widanga (Embelia ribes), a group of researchers evaluated the antifungal activity of the plant. They found, the extract showed antifungal activity against eight different fungi. The inhibition zones observed were: Colletotricum crassipes (18mm), Cladosporium (17. 5 mm), Armillalria mellea (17mm), Oryzae (16.5 mm). Aspergillus niger (16.5), Rhizopus, Aspergillus terreus ans Candida albicans less than 15.5-16.5. Of all concentrations high inhibition zone was observed at the concentration of 2mg. 
By definition, anthelmintics are drugs that expel / eradicate parasitic worms from the body, by either inhibiting or killing them. Accordingly anthelmintics are called as vermifuges (inhibiting drugs) or vermicides (killing drugs). Honigberger reported Widanga, (Embelia ribes Burm.) as a vermifuge. After him almost all researchers described Widanga, (Embelia ribes Burm. f.) as 'vermifuge' anthelmintic. 
Watt GA reported addition of powdered seeds of Widanga (Embelia ribes) in curdled milk in combination with castor oil for effective eradication of tape worms. 
Embelin a benzoquinone shows anthelmintic activity. It is also ovicidal. Its activity is comparable to livamisole. While the parasites develop genetic resistance to levamisole, albendazole, ivermectin and mebendazole, the researchers found that the parasites have not developed resistance to embelin and Widanga (Embelia ribes) extract or powder. 
A Herbal monograph reported, Embelin is effective against tape worm but not against round worm or hookworm. , 
Furthermore, embelin was found to active against Trypanosoma cruzi trypomastigotes. 
The aqueous extract of Widanga (Embelia ribes) containing embelin exhibited anthelmintic activity against a variety of worms. This activity was comparable to piperazine citrate. 
The ethanolic extract of seeds of Widanga (Embelia ribes) was evaluated for anthelmintic activity against round worm. In vitro graded doses of the extract (10, 50, 100 and 200 µg/ml) showed a significant anthelmintic activity against round worm. Levamisol and Ivermectin were used as reference drugs. , 
Benzoquinone derivatives have been reported to possess antiplasmodial activity. Embelin being a benzoquinone derivative was studied for its antimalarial activity. The study suggested that embelin is a useful antimalarial phytochemical. 
Embelin is found to be useful in the treatment of Plasmodium falciparum malaria. 
According to a group of researchers, embelin is not ideal to be suggested as an anti-malarial agent to be used against Plasmodium falciparum malaria, but it has a potential to ameliorate chloroquin resistance. 
Actions on the Skin:
A study was designed to investigate the effects of embelin on lipopolysachharide-induced TNF-α production in mice and in human keratocytes and also to study the effects of embelin on acute and chronic skin-inflammations in mice. By blocking the synthesis of TNF-α, embelin inhibited topical edema in the ear of mouse leading to reduction in the skin weight and thickness, reduction in inflammatory cytokine production, neutrophil-mediated myeloperoxidase activity. These observations were supported by histopathological studies. Embelin was also effective in reducing inflammatory damage induced by chronic exposure to TPA. Thus embelin has anti-inflammatory activities in both acute and chronic dermatitis. 
Wound Healing Activity:
In a study on Swiss Albino Rat model, the wound healing activity of embelin isolated from the ethanol extract of the leaves of Widanga (Embelia ribes) was evaluated. The ethanol extract at 30 mg/ml showed rapid epithelization of the incised wound and faster rate of wound contraction. In dead space wounds also formation of granulation tissue was rapid and increased strength of collagen tissue. Both the observations were supported by histological study. 
Actions on Musculoskeletal System:
It is well known that most malignant tumors metastasise in bones. Thereafter osteoclastic activity increases resulting in osteolysis or destruction of the bone. Embelin has been shown to bind and inhibit x-linked inhibitor of apoptosis protein and prevent the bone loss. Embelin also has been shown to induce the ostoblastic activity and the bone regeneration. 
Actions on Hematopoetic System:
Signal transducer and transcription activator-3 (STAT-3) mediates cellular responses to interleukins. Phosphatase and tensin (PTEN) homolog is a protein that, in humans, is encoded by the PTEN gene. Mutations of this gene are a step in the development of many cancers. 
By down-regulating the expression of STAT-3 regulated gene products, embelin suppresses the cell proliferation and survival of multiple myeloma via the protein tyrosine phosphatase PTEN 
Actions on the Eye:
Muller glia or Muller cells are a type of retinal glial cells. They maintain the stability of the retinal extravascular environment. 
Hyperglycemia induces alterations in the Muller cells such as cell proliferation and VEGF production. This is the precursor of development of diabetic retinopathy. Embelin counter acts these alterations and prevents the development of diabetic retinopathy. 
Actions on the Breast:
MCF-7 is the acronym of Michigan Cancer Foundation-7. MCF-7 is a breast cancer cell line isolated in 1970 from a 69 year old Caucasian woman. This cell line is used in cancer research.
A group of researchers found that embelin induced apoptosis of MCF-7 breast cancer cells in the G2/M phase via the mitochondrial pathway in a dose-dependent manner. However the exact mechanism of action remains unclear. 
A study shows that embelin primes inflammatory breast cancer cells (IBC cells) for TNF-alpha-related-apoptosis-inducing-ligand (TRAIL) mediated apoptosis by its direct action on the anti-caspase activity of X-linked inhibitor of apoptosis protein (XIAP). 
Mortalin is a protein involved in multiple basic mitochondrial processes, including energy metabolism, free radical generation. p53 is a key tumor suppressor protein that eliminates genetically unstable cells. Targeting mortalin by embelin causes activation of tumor suppressor p53 and deactivation of metastatic signaling in breast cancer. , 
By various chemical reactions and chemical processes disalts and diamines of embelin are developed. Embelin, its disalts and diamines exhibit anti-pyretic and anti-inflammatory activity. 
Actions on CNS:
Action on traumatic brain injury:
Traumatic brain injury is a serious problem. Both in children it can be life threatening and even fatal. The survivors suffer from many complications. A study revealed that embelin can be useful in the treatment of some complications. 
Effect on autoimmune encephalomyelitis:
A study showed that embelin suppressed human CD 14(+) monocyte-derived dendritic cells (DC) differentiation, maturation and endocytosis. Embelin also inhibited the stimulatory function of mature dendritic cells on allogenic T cell proliferation in vitro. Embelin also prevents the demyelination of nerves. Thus embelin has potent anti-inflammatory and immunosupressive properties. This makes it a potential therapeutic agent for the treatment of autoimmune encephalitis and inflammatory diseases of CNS. 
Embelin is a non-norcotic analgesic effective by oral, intramuscular and intravenous routes. Its action is not antagonized by naloxone indicating a different central site of action. Furthermore in vivo studies indicate that mu and kappa binding sites in the brain may be involved in the analgesic action of embelin. Its analgesic action is as strong as morphine. Embelin is not habit forming and not addictogenic and is remarkably free from adverse effects. This makes it safe analgesic for long term use. , , 
A study was aimed at evaluating anxiolytic activity of embelin isolated from Widanga (Embelia ribes). The study group found embelin to be a potent anxiolytic agent. Needless to say that the anxiolytic activity was dependent on the dose used.
To evaluate the antidepressant activity of embelin, intraperitonial injections of embelin were administered at 2.5 and 5 mg/kg body weight 30 minutes prior to induction of experimental depression in Swiss albino mice of both sexes. Embelin exhibited antidepressant activity. The effective dose was 5 mg/kg body weight which was as good as imipramine 15 mg/kg body weight.
Since, the anxiolytic effect of embelin was shown to be mediated through GABA system, similar mechanism of antidepressant action cannot be ruled out. 
In Ayurveda Widanga (Embelia ribes) was claimed to be useful in the treatment of diseases of the nervous system. In a study on rodents, embelin was administered orally to the study animals at 5 and 10 mg/kg body weight once a day for 15 days before exposing them to apomorphine injections. The study showed that embelin restored the elevated levels of dopamine, noradrenaline and serotonin to normal. Embelin wast more effective at the dose of 10 mg/kg body weight than at the dose of 5 mg/kg body weight. Researchers concluded that embelin possesses antipsychotic activity. In the research paper researchers did not explain the exact pharmacological mechanism of anti-psychotic activity of embelin. Further research is needed in this regard. 
In experimental animals, embelin administered by intraperitonial injections at 2.5, 5 and 10 mg / kg body weight significantly inhibited seizures induced by phentylenetetrazole and electroshocks. The effect was dependent on the dose of embelin used. The anticonvulsant activity of embelin was comparable to phenytoin and diazepam. The observations suggest that embelin can be useful in the treatment of grand mal and petit mal epilepsy. 
Actions on Sickness behavior:
Sickness behavior is a coordinated set of adaptive behavioural changes that develop in illness especially during the course of infection. A study was undertaken to investigate actions of embelin on lipopolysaccharide (LPS)-induced sickness behavior in adult Swiss albino mice. The animals were pre-treated with 10 and 20 mg/kg body weight of embelin for 3 days and then challenged with LPS 400 µg/kg body weight. Anti-inflammatory, antioxidant, anxiolytic and neuroprotective actions of embelin attenuated the behavioral changes induced by LPS. Embelin reduced anorexia, prevented anhedonia (inability to feel pleasure) and ameliorated brain oxidative stress markers. The study demonstrated protective effects of embelin on LPS-induced sickness behaviour in mice.
Effect on focal ischaemia:
In cerebral ischaemia the brain receives inadquately oxygenatd blood and in inadequate quantity too. This generates reactive oxygen species that inflict brain damage. Embelin is a potent antioxidant. Its chemical structure resembles that of co-enzyme Q 10. Patel and Gohil investigated the effect of embelin on focal cerebral ischaemia using middle cerebral artery occlusion model in male Wistar rats. The occlusion resulted in infarct in the middle cerebral artery territory. Male Wister rats were then treated with embelin at doses of 50, 75 and 100 mg/kg body weight. Embelin not only decreased the area of infarct but also increased super oxide dismutase (SOD) levels 
Effects on global ischaemia-reperfusion injury:
A study was designed to investigate the protective effect of embelin on global ischaemia-reperfusion brain injury in rats. Transient global ischaemia was induced by occluding both internal carotid arteries for 30 minutes followed by 24 hour reperfusion. Physical, biochemical and histoppathological changes were recorded. The animals pretreated with emnelin at doses of 25 and 50 mg/kg body weight were protected from ill effects of ischaemia. Their locomotor activity was preserved. Pretreatment and treatment with embelin also reduced the lipid peroxidation and increased glutathione-S-transferase activity in the brain. The histopathological studies revealed decreased area of cerebral infarction. These findings suggest that embelin is a potent neuroprotective agent and may prove to be useful in prevention and treatment of stroke. 
Embelin has been shown to relieve some effects of ischaemic stroke. 
Effects on Huntington's disease:
Huntington's disease (HD) is a progressive neurodegenerative disorder associated with severe degeneration of basal ganglia neurones, which affects muscle coordination. It leads to decline in mental function and behavioural symptos. 3-Nitropropionic acid (3-NP) causes severe neurotoxicity in animals which resembles Huntington's disease in humans. A study was designed to study the protective effect of embelin in 3-NP induced neurotoxicity in adult Wistar rats. Neurotoxicity was induced in Wistar rats by administering of 3-NP at the dose of 15 mg/kg body weight for 7 days. From 8 th day onwards the animals were co-treated with embelin (10 and 20 mg/kg body weight) for 7 days. The animals treated with embelin showed improvement in neurological symptoms and behaviour. 
Effect on Multiple Sclerosis (MS):
A chronic progressive damage to the sheaths of nerve cells in the brain, spinal cord, optic nerve etc. is termed as multiple sclerosis (MS). It is an autoimmune disease due to chronic inflammation. Xue et al demonstrated that embelin possesses a strong therapeutic potential for autoimmune anti-inflammatory conditions in multiple sclerosis (MS). 
Effect on malignant glioma:
A study was designed to investigate whether embelin could have a therapeutic effect in glioma. The study showed that embeiln suppressed the proliferation of human glioma cells. In addition, embelin induced apoptosis in human glioma cells by inhibiting NF-κ B. The results indicate that embelin could be a potent novel therapeutic modality for glioma. 
Actions on CVS:
To investigate the cardioprotective effect of and possible mechanism of action of embelin on isproterenol-induced myocardial infarction in rats, rats were pretreated for three days with embelin at a dose of 50 mg/kg body weight. There after isoproterenol was injected subcutaneously at the dose of 85 mg/kg body weight at an interval of 24 hours for 2 consecutive days. Serum was analysed for cardiac specific injury biomarkers, lipids and lipoprotein contents. Heart tissues were isolated for histopathology, antioxidant and mitochondrial respiratory enzyme activity assays and westernblot analysis. Results showed that pretreatment with embelin significantly protected the myocardium from isoproterenol-induced cardiaca injury. This suggests that embelin may have a potential benefit in preventing ischaemic heart disease. 
In another study on rabbits some researchers investigated the protective effects of embelin on myocardial ischaemia-reperfusion injury following cardiac arrest. Following cardiac arrest, hemodynamics, pro-inflammatory cytokines, cardiac troponins, necrosis ratio, apoptotic index, nuclear factor-kappa B p65 and histological damage were evaluated. They found that animals treated with embelin showed improvement in myocardial morphology. These results were attributed to anti-inflammatory activity of embelin. 
Embelin has the ability to lower elevated systolic blood pressure. 
Actions on RS:
A study was aimed at investigating the effect of embelin on lipopolysachharide (LPS)-induced acute respiratory distress syndrome in rats. Embelin was administered orally to rats at 5, 10 and 20 mg/kg body weight for four days before lipopolysachharide (LPS) challenge. The results showed that embelin prevented pO2 down-regulation and pCO2 augmentation. Embelin also attenuated histopathological changes in the lung in acute respiratory distress syndrome. This was attributed to anti-inflammatory and protective effect of embelin against LPS-induced airway inflammation and obstruction. 
Embelin induces apoptosis in lung cancer cells via activation of p38/JNK pathway. Reactive oxygen species play a crucial role in embelin- activity. 
Actions on GI System:
Administration of embelin orally at 75 mg/kg per day for 15 to 30 days to male rats caused significant elevation in the uptake of D-glucose, L-alanine, L-leucin and calcium in the small intestine. Embelin also produced significant increase in enzymes sucrase, maltase, lactase, alkaline phosphatase and leucine aminopeptidase. All these changes returned to control levels on withdrawal of the drug. 
In an experimental study, intra-rectal administration of 3% acetic acid for 7 days induced ulcerative colitis in rats. When treated with embelin at doses of 25, 50 and 100 mg /kg body weight there was a significant remission in the colitis. The treatment also reduced significantly the colonic myeloperoxidase activity, lipid peroxides and serum lactose dehydrogenase. The treatment also increased the decreased glutathione. The histopathological also supported the remission of the disease. The protective effect of embelin was attributed to the anti-inflammatory and antioxidant activities of the phytochemical. 
In another experimental study, colitis was induced in BALB/c mice by feeding them with 5% dextran sodium sulfate (DDS) for 7 days in drinking water. Embelin was then administered orally for 7 days to these animals at 10, 30 and 50 mg/kg body weight doses. The treatment significantly suppressed weight loss, diarrhea, bleeding and infiltration of immune cells. The histopathological study showed that embelin reduced the mucosal edema and the loss of crypts induced by dextran sodium sulfate. Furthermore embelin inhibited the abnormal secretions and mRNA expressions of pro-inflammatory cytokines. 
Actions on Pancreas:
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces apoptosis in a wide variety of cancer cells. TRAIL does not exert toxic effects on normal cells. Therefore TRAIL may be a suitable agent for anti cancer therapy. In various pancreatic cancer cell lines TRAIL induced apoptosis. However the cancer cells soon developed resistance. Embelin reduced the resistance to TRAIL by the pancreatic cancer cells. 
Actions on the Liver:
The rat liver is susceptible to damage induced by carbon tetrachloride (CCl4) through production of reactive metabolites, namely trichlormethyl-free radicals. After the induction of liver damage by carbon tetrachloride the animals were treated with embelin by oral administration of 25 mg/kg body weight from day 1 to 15. With embelin treatment the peroxidative damage was minimal. The antioxidant activity of embelin was found to be useful to protect the liver against carbon chloride- induced hepatotoxicity in rats. The hepatoprotection by embelin was superior to that by silymarin. 
Another group of researchers use N-Nitrosodimethylamine and Carbon tetrachloride to induce hepatootxicity. They then treated the animals with embelin. Their results were similar as described above. 
Alcoholic and non alcoholic liver disease:
Anti-inflammatory, antioxidant and free radical scavenging activity of embelin is useful in protecting the liver against alcoholic and non alcoholic liver disease. The effective dose of embelin is found to be 50 mg/kg body weight. 
Anti-inflammatory is useful in the treatment of certain hepatic malignancies and cancer cell metastasis. 
Embelin causes inhibition of cancer cell proliferation but does not induce cancer cell apoptosis. By this mechanism embelin inhibits proliferation of cholangiocarcinoma. 
Embelin 50 mg /kg body weight (in combination with curcumin 100 mg/ kg body weight) prevented the induction of hepatic hyperplastic nodules, body weight loss, hypoproteinemia and elevation of liver enzymes in adult male Wistar rats.
Actions on Metabolism:
To evaluate efficacy of embelin in the treatment of obesity, male Wistar rats were fed on high fat diet for 28 days. Obese rats were then treated with embelin, 50 mg/ kg body weight for 21 days. Embelin treatment reduced body weight, reduced BMI, normalized blood pressure, serum lipid levels as well as coronary artery risk and atherogenic index. Embelin reduced serum glucose levels by 24.77 %, insulin by 35 % and leptin by 43.39%. Furthermore, embelin treatment significantly decreased the byproduct or degradation products of fat metabolism (TBARS) in the liver. Embelin increased the levels of superoxide dismutase (SOD), glutathione (GSH). The effects of embelin were similar to 10 mg/ kg body weight of orlistat. Embelin could be valuable in the development of new drug therapies to prevent and treat obesity, hyperlipidemia, diabetes, some complications of diabetes and oxidative stress. 
Streptozotocin-induced diabetic rats were treated with embelin at 25 and 50 mg/kg body weight per day for 3 weeks. They showed a significant reduction in plasma glucose, glycosylated haemoglobin and pro-inflammatory mediators. Embelin also improved altered architecture of β-islet cells of pancreas and hepatocytes. This activity is attributed to the anti-inflammatory activity of embelin. The study suggests that embelin can be a useful adjuvant for the treatment of type 2 diabetes. 
Another group of researchers induced diabetes in rats by using alloxan. They treated the animals with embelin. Their results were similar to the results mentioned above 
Embelin 50 mg/kg body weight administered to type 2 diabetic rats not only controlled the blood sugar but also modulated the altered lipid lipid profile. Embelin also reduced the weight, regulated insulin resistance, altered β cell dysfunction, inhibited adiponectin activity and regulated insulin mediated glucose uptake in epididymal adipose tissue. These effects were attributed to antioxidant activity of embelin.
Embelin increases the antioxidant status in the pancreas. This prevents the β cell apotosis and protects them. The histopathological study of pancreas of the diabetic rats shows degenerated pancreas with reduced β cell counts, while embelin treatment was shown to significantly protect the β cells. 
Actions on Urinary System:
A study was designed to evaluate the nephroprotective and anti-polyuric activity of embelin on lithium-induced nephrogenic diabetes insipidus (NDI). Diabetes insipidus was induced in rats by administering lithium chloride 4 mg/kg body weight per day for 6 days. After induction embelin 50 and 100 mg/kg body weight was administered orally once a day for 21 days. At 0, 7, 14 and 21 days the body weight, protein in urine, creatinine in urine, blood urea nitrogen serum creatinine levels were assessed. The results showed that embelin 50 and 100 mg/kg body weight showed increase in body weight and decrease in protein and creatinine in urine and normalization of blood urea nitrogen and serum creatinine. Histopathological examination of the kidney showed reduced vascular degeneration of tubules and slight degeneration and dilatation of renal tubules. These effects of embelin were due to its antioxidant activity. The decreased urine excretion may be due to the blocking of sodium channels. 
Actions on Male Reproductive System
Embelin administered by subcutaneous route at 0.3, 0.4 and 0.5 mg /kg body weight for 35 days to experimental animal model reduced sperm count and altered the testicular histology. Embelin was found to possess anti-androgenic activity. Embelin was used by some couples as an oral contraceptive. This is very cheap and can be a useful oral contraceptive for village-couples. 
Daily subcutaneous injection of embelin isolated from the seed extract of Widanga (Embelia ribes) at a dose of 20 mg/kg body weight to male albino rats for 15-30 days revealed the inhibition of: (1) motile sperm count in the epididymis (2) the enzyme activity of glycolysis (3) energy metabolism (4) fertility parameters. These changes were reversible.
Treatment with embelin causes both in vitro and in vivo morphological changes in spermatozoa: (1) decapitation of spermatozoal head (2) discontinuity of outer membranous sheath in the mid-piece and and the tail region and (3) alteration in the shape of the shape of the cytoplasmic droplet in the tail. Embelin also caused a significant reduction in the sperm count, motility of the sperms and weight of the testes. All these contribute to antifertility activity of embelin in male albino rats. 
Having confirmed the efficacy of embelin as an effective contraceptive or antifertility agent, the next challenge was to determine the effective therapeutic dose. After studying various biochemical, hormonal and histopathological parameters and different routs of administration the doses finalized were: (1) Intramuscular injection- 5.0 mg/kg body weight (2) Oral administration (suspension)-10 mg/kg body weight (3) Oral tablet of base 50 mg/kg body weight (4) Subcutaneous injection (minimum effective dose)-20 mg /kg body weight 
Actions on the prostate:
Embelin ameliorates testosterone-induced hyperplasia in rats. 
Embelin induces apoptosis in PC3 cell line of the prostate cancer cells. But the exact mechanism is not known. 
Embelin enhances therapeutic efficacy of ionising radiation in prostate cancer 
Actions on Female Reproductive System:
In an experimental study on female Sprgue-Dawlee rats having regular estrous cycle, embelin at doses of 10 and 20 mg/kg body weight decreased the plasma levels of estrogen and progesterone. This anti-fertility effect in females is due to suppression of ovarian function. , 
Treatment of female rats with embelin reduces the serum levels of estradiol and progesterone. Embelin also reduces the weight of ovaries uterus. These effects of embelin interfere with the implantation of fertilized ovum in the uterus. 
That herbal therapy is safe and devoid of side effects is a myth. Administration of embelin at a dose of 120 mg/kg body weight to female rats for six weeks caused severe pathological changes in the liver and kidneys such as marked necrotic changes, perinuclear vacuolation, tubular damage. The adrenals showed marked hypertrophy. There was increase in acid and alkaline phosphatase. However the histological features of spleen remained unchanged. 
Embelin is reported to decrease tumor size and inhibit activity of serum enzymes viz. acid phosphatase, T-glutamyl transferase, lactate dehydrogenase, aldose etc. in rats with experimental fibrosarcoma. Embelin interferes with carbohydrate and aminoacid metabolism in tumor bearing animals.
The osteoclasts are responsible for the osteolysis in bone metastases of the tumor. RANKL (receptor activator for nuclear factor κB ligand), a member of the TNF superfamily and an activator of the NF- κB signaling pathway, has emerged as a major mediator of bone loss, commonly associated with cancer and other chronic inflammatory diseases. , 
Nuclear factor-kappa B (NF- κB) regulates several gene associated with inflammation, proliferation, carcinigenesis and apoptosis. Embelin inhibits tumor necrosis factor alpha (TNF-α) induced NF- κB activation. Thus embelin prevents carcinogenesis. Furthermore, embelin down-regulates gene products involved in cell survival, proliferation, invasion and metastasis of the tumor. 
Mortalin is a protein involved in multiple basic mitochondrial processes, including energy metabolism, free radical generation. p53 is a key tumor suppressor protein that eliminates genetically unstable cells. Targeting mortalin by embelin causes activation of tumor suppressor p53 and deactivation of metastatic signaling. , 
TNF-α is synthesized as a membrane anchored protein, pro-TNF-α. The soluble component of pro-TNF-α is then released in the extra- cellular space by the action of a protease, TNF-α converting enzyme. This the first step in development of inflammation and cancer. Embelin inhibits TNF-α converting enzyme and cancer cell metastasis. 
In the normal quiescent state of vasculature, only 0.01% of endothelial cells (ECs) are proliferating. However during angiogenesis the endothelial cells proliferate markedly. This proliferation depends on mitochondrial oxidative phosphorylation. This neo-angiogenesis is the key stage in tumor growth. The antooxidant activity of embelin inhibits endothelial mitochondrial respiration and impairs neo-angiogenesis and tumor growth. 
Safety and Toxicity:
Mice treated with embelin administered orally at doses of 50-100 mg/kg body weight did not show acute toxicity. The subcutaneous dose of 10 mg/kg body weight for 10 weeks was also well tolerated by animals without any side effect. Embelin administered orally to rats from 10 mg to 3 g/kg body weight did not show any adverse effect on heart, liver, kidney and bone marrow.
The female rats of reproductive age having normal cycles however did show toxicity even on short term use. Administration of 120 mg/kg body weight was a safe dose, however higher dose was unsafe. The dose also caused liver and kidney damage. Embelin can cause hormonal disturbances in males and females. Embelin can cause morphological alterations in the adrenals, testes and ovaries.
It can be said, embelin is safe to use even for long term use in therapeutic doses. 
Embelin is cotraindicated during pregnancy, lactation.
Newly married couples should not use embelin as a contraceptive.
Intramuscular injection- 5.0 mg/kg body weight
Oral administration (suspension)-10 mg/kg body weight
Oral tablet of base 50 mg/kg body weight
Subcutaneous injection (minimum effective dose)-20 mg /kg body weight
By the success in synthesis of embelin, researchers were inspired to develop derivatives of embelin. By combining embelin with various metals such as sodium, potassium, copper, cobalt, nickel, zinc etc. salts of embelin were synthesized. These derivatives showed better pharmacological actions than natural embelin. Natural embelin exhibited anticancer activity. The search for better and better anticancer drugs is incessant. This led to develop better anticancer derivatives of embelin.
I wish to present a short review of embelin derivatives and their pharmacology.
Anti-inflammatory, analgesic, antioxidant and free radical scavenging activities.
Recently embelin was condensed with various aromatic substituted primary amines to yield ten new derivatives. At 10-20 mg/kg body weight these componds show anti-inflammatory, analgesic, antioxidant and free radical scavenging activities. 
Aromatic aldehyde derivatives of embelin show antibacterial activities against gram positive and gram negative bacteria including multidrug resistant Staphylococcus aureus. 
Cobalt [Co(II)], Nickel [Ni(II)] Copper [Cu (II)] and Zinc [Zn (II)] derivatives of embelin show antibacterial activity against Staphylococcus aureus and Pseudomonas aeruginosa. At higher concentrations these derivatives show antibacterial activity comparable to rifampicin.
In a study various derivatives of mbelin showed antimicrobial activity against Staphylococcus aureus and Pseudomonas aeruginosa, Escherichia coli and Candida albicans. 
Nanoparticles of embelin and its metal complexes exhibit potent antidiabetic activity. , 
All derivatives of embelin exhibit anticancer activity against a variety of cancer. Many research papers are available for references on this subject. , , 
Molecular formula: C19H30O4 
Many pharmacological actions of rapanone are similar to those of embelin. Here I have selected those that are different from those of embelin especially in their mechanism of action.
Anti-inflammatory and Analgesic activity
Rapanone is a mild anti-inflammatory, anti-oxidant agent. Increased activity of phospholipid A2 (PLA 2) in synovial fluid is an important cause of inflammation of joints. Rapanone is a selective and potent human synovial PLA2 inhibitor. Rapanone showed a mild anti-lipoperoxidative profile in rat liver microsomes and inhibited degranulation of human neutrophils. Rapanone decreases carageenan induced paw edema and inflammations in the synovial membranes of joints. Rapanone is very efficient in controlling inflammatory process by different routes of administration. Rapanone is a potent analgesic. , , 
Oxidative stress generates reactive oxygen species (ROS). They damage various tissues and organs. To stabilize health it is necessary to neutralize or deactivate them. In an experimental study rapanone was found to scavenge oxygen free radicals and act as antioxidant agent. 
In an in vitro experimental study rapanone at a concentartion of 200 µg/ml displayed anti-amoebic activity against Entamoeba histolytica. In weanling Wistar rats administration of rapanone 200 mg /kg body weight for 4 days cured intestinal amoebiasis and in golden hamsters at 100 mg/kg body weight for 4 days cured hepatic amoebiasis. 
Oral administration of 60 and 120 mg/kg body weight of rapanone to female mice reduced the number of pregnancies suggesting anovulatory cycles. Rapanone also inhibited the implantation of trophoblast. Daily administration of rapanone to male mice showed antispermatogenic effect. There were no acute toxicity at the doses tested during research. 
In experimental studies rapanone showed anticancer activity against adenocarcinoma of the breast, colorectal adenocarcinoma DLD-1 cells, small cell lung cancer A549 cells, hepatocarcinoma Hep G2 cells, mesothelioma SPC 212 cells. Antiproliferative activity of rapanone-induced apoptosis in these cancer cells. 
Rapanone shows anthelmintic activity. Rapanone is also inhibitor of angiotensin converting enzyme, hence useful in lowering raised blood pressure. 
Molecular formula: C35H52O8 
Vilangin was synthesized by condensation of embelin with formaldehyde in acetic acid.
Vilangin is bright orange-yellow in color, insoluble or sparingly soluble in common organic solvents, but easily soluble in dioxane and nitrobenzene. It is soluble in water-alcohol.
Many pharmacological actions of vilangin are similar to those of embelin. Here I have selected those that are different from those of embelin especially in their mechanism of action. , , 
Vilangin inhibits angiogenesis. This delays the process of wound healing. Suppression of angiogenesis also reduces the vascularity of malignant tumors, exerting antimalignant effect of vilangin. 
Vilangin relieves itching of the skin, purifies blood and lymph. Vilangin is anthelmintic. 
At the concentration of 62.5 µg/mL vilangin showed antibacterial activity against Staphylococcus epidermidis and Salmonella typhimuricum. The free radical scavenging activity of vilangin was maximum at a concentration 100062.5 µg/mL. Antioxidant power of vilangin was two-fold higher than the standard antioxidants used in experimental studies. Vilangin showed a potent cytotoxic activity in vitro against A549 lung adenocarcinoma cell line at a dose of 500 µg/mL. Vilangin can thus be useful as a new anticancer drug. 
In diabetic rats, vilangin reduced the body weight, elevated plasma glucose and plasma insulin. Vilangin also altered the lipid profile.
This study suggests that vilangin may be useful in the prevention and treatment of obesity and type 2 diabees. 
Pharmacological actions of vilangin are similar to the actions of estrogen. In male albino rats vilangin shows antispermatogenic and antifertility activity. 
Embelic acid is same as embelin (See above)
Molecular formula: C17H25KO4 
Potassium embelate is a potassium salt of embelic acid.
Potassium embelate was administered orally and intravenously at a dose of 20 mg/kg body weight to rats to study the pharmacokinetics. The results showed that the absorption of potassium embelate was complete and fast (bioavailability 97%). The disposition half life on intravenous administration was 9.7 hours and 11 hours on oral administration. High concentrations of the drug were found in the brain between 0.25 and 2 hours. The kidney plays a major role in the excretion of the drug. , 
Potassium embelate shows antibacterial activity against Enterobacter aerugenes and antifungal activity against Candida species and some other fungi. 
Potassium embelate with copper-bound Streptomyces castaneoglobisporus tyrosinase is a potent tyrosinase inhibitor. This information could contribute for further development of tyrosinase inhibitors for the prevention of hyperpigmentation. 
Potassium embelate is a non-narcotic analgesic. It is effective by oral, subcutaneous, intramuscular routes of administrations. It acts centrally to produce analgesia. Its effect is not antagonized by nalaxone. This suggests that it has a different central site of action. It is as powerful analgesic as morphine but is not habit forming. It increases the threshold to pain sensation or perception. It is said to inhibit COX-2. But its exact mechanism of action is unclear. Potassium embelate is not a potent anti-inflammatory agent. But its analgesic activity relieves joint pains. , 
Certain analgesics affect the metabolic status of the brain and other parts of the nervous system. Following administration 30 mg/kg body weight of potassium embelate to albino rats, there occurs alteration in the energy status of the brain, glycogenesis, glycogenolysis and cerebral turnover of noradrenalin. The antinociception begins within 15 minutes, reaches maximum in 30 minutes and diminishes by 90 minutes. Further studies would clarify the relationship between the brain metabolism and nociception. 
A study was carried out on the rat brain to clarify the characterization of binding sites for potassium embelate, a potent centrally acting analgesic compound. The results indicate that mixed mu and kappa binding sites in the brain may be involved in the analgesic action of of potassium embelate. 
Embelic acid is contained in the fruit of Widanga (Embelia ribes). Ammonium embelate is ammonium salt of embelic acid. It is grayish violate powder. It is irritant to mucous membranes causing violent sneezing. Jt is used as anthemintic (in children 200 mg and in adults 350-400 mg). In children ammonium embelate is administered with honey for three consecutive days preceded by milk diet and followed by a dose of castor oil. Similar is the regimen for adults. 
Molecula formula: C9H8O4
Caffeic acid is a yellow solid organic compound found in all plants. It is susceptible to autooxidation. Glutathione, ascorbic acid have protective effect on oxidation.
Caffeic acid has antioxidant, anti-inflammatory and immunomodulatory activity.
Antioxidant activity of caffeic acid makes it a natural fungicide against Aspergillus flavus.
Caffeic acid shows anticancer activity against human fibrosarcoma cell line in experimental studies. Oral administration of high doses of caffeic acid in rats caused stomach papillomas, but in the same study when high doses of caffeic acid were combined with other antioxidants showed a significant decrease in growth of colonic cancers. These effects of caffeic acid were attributed to alterations in formation of metabolites of caffeic acid by bacteria in the gut of rats.
Caffeic acid is thiamine antagonist. No other untoward effects of caffeic acid are recorded in humans. 
Ikeda et al reported that caffeic acid has valuable properties such as antioxidant, antiinflammatory, antiviral, antidepressant, antidiabetic and anticancer. They also reported that caffeic acid inhibits multiplication of herpes simplex virus. 
Oxidative stress and vascular endothelial growth factor (VEGF) are implicated in retinal angiogenesis and retinopathy in diabetics. Caffeic acid was reported to show anti-angiogenetic effect on retinal neovascularization. This activity is attributed to inhibition of aldose reductase by caffeic acid. 
In an in vitro study caffeic acid was found to lower the raised LDL. It also prevented the oxidation and metabolic modification of LDL. This effect was dependent on the dose of caffeic acid used. 
Caffeic acid is a mild stimulant and reduces fatigue. It can cause and worsen insomnia.
Caffeic acid is said to be safe during pregnancy however it should be avoided during breast feeding. 
Caffeic acid is a natural product containing catechol with α, β- unsaturated carboxylic acid chain that has hepatoprotective properties. 
Molecular formula: C8H8O4
Vanillic acid is a phenolic acid found in many plants and in plant extracts in some form of vanilla. It is a flavouring and scent agent that produces a pleasant odor. Vanillic acidia is a metabolic byproduct of caffeic acid and is often found in the urine of humans who have consumed tea, coffee, chocolate and vanilla-flavoured confectionery.
Vanillic acid selectively and specifically inhibits 5' nucleotidase activity. 
Vanillic acid shows anti-inflammatory, immununomodulatory and hepatoprotective activity. 
In experimental studies on animal models Vanillic acid was found exert a good anti-inflammatory and analgesic activity in a wide range of murine inflammation models. Its mechanisms of action involve antioxidant effects and NFκB-related inhibition of pro-inflammatory cytokine production. 
Vanillic acid attenuates oxidative stress and improves cognitive function. 
A study was undertaken to compare the antioxidant and free radical scavenging properties of vanillin, vanillic acid and other 13 phenolic compounds. The results showed that antioxidant and free radical scavenging activities of vanillic acid were poor. 
At 200 mg /L vanillic acid shows maximal antimicrobial activity. 
By inhibiting 5'nucleotidase and platelet aggregation Naja naja venom inhibits blood coagulation.Thus Naja naja venom poisoning induces bleeding. By inhibiting Naja naja venom activity, vanillic acid acts as an antidote for Naja naja venom poisoning. 
In male Wistar rats vanillic acid at 5 mg and 10 mg/kg body weight showed cardioprotective effect against isoprenalin (100 mg/kg body weight) induced cardiotoxicity. These effects of vanillic acid were attributed to anti-inflammatory and antioxidant activities of vanillic acid. The cardioprotective activity was supported by ECG recordings, studies of troponins and histopathology of myocardium. 
Vanillic acid counter acts the ill effects of carbon dioxide excess or carbon dioxide poisoning as was observed in controlled experiments in healthy young adult male volunteers. 
In experimental studies on animal models, dextran sulpfate sodium is used to induce ulcerative colitis. Vanillic acid significantly suppresses the expression of cyclooxigenase-2 and the activation of NFκB p65 in colon tissue. Thus vanillic acid may be useful for the treatment of ulcerative colitis. 
Via improving hepatic insulin signalling and alleviating inflammation vanillic acid ameliorates insulin resistance in rats fed on high fat diet. These findings suggest that vanillic acid may be used to prevent type 2 diabetes. 
Vanillic acid by preventing glycation can prevent diabetic neuropathy. It also prevents apoptosis of nerve cells. 
In vitro direct exposure of spermatozoa to vanillic acid a doses 25-100 mg % did not significantly affect their motility or fertilizing effect. Vanillic acid does not interfere with enhancement of fertilization by other chemicals such as piperine as was shown by studies in hamsters. 
Molecular formula: C16H18O9
Chlorogenic acid is the ester of caffeic acid. The term "chlorogenic acids" refers to a related polyphenol family of esters. Despite the word "chloro", chlorogenic acid does not contain chlorine. Instead the name comes from the Greek, pertaining to the green color produced when chlorogenic acids are oxidized. Chlorogenic acid is freely soluble in ethanol and acetone. Chlorogenic acid is found in coffee and many plants. 
Anti-inflammatory activity of chlorogenic acid was examined in lipopolysaccharide (LPS)-stimulated mice. The results showed that chlorogenic acid exerted anti-inflammatory activity as was evident by lower levels of inflammatory markers. 
In rats chlorogenic acid at doses 50 and 100 mg/kg body weight exhibited anti-inflammatory, antinociceptive and antipyretic action within two hours of experimental procedure. Chlorogenic acid did not inhibit febrile response induced by lipopolysaccharide (LPS). The highest tested dose was 200 mg/ kg body weight which neither produce any untoward side effects nor any toxic effects. 
Anti-inflammatory and antioxidant activity:
Chlorogenic acid controls oxidative stress and shows anti-inflammatory activity. 
Although chlorogenic acid is a good antioxidative agent it is unstable when exposed to light and heat. However recently it has been made stable by encapsulating it with β-cyclodextrin (β-CD) and hydroxypropyl-β-cyclodextrin (HP-β-cyclodextrin). 
To evaluate effect of topical application of 1 % ointment of chlorogenic acid, excision wounds were inflicted in Wistar rats. The wounds were dressed with 1% ointment of chlorogenic acid. The anti-inflammatory and antioxidant properties of chlorogenic acid accelerated the process of wound healing. 
As physiological importance of an orally administered drug depends on its absorption in the intestine and action on target tissues, an in vivo intestinal ischemia-reperfusion model was used to evaluate antioxidant activity of chlorogenic acid. The study showed that chlorogenic acid protected the intestinal tissues from ischemia-reperfusion injury. 
Bronchial asthma is a chronic inflammatory disease characterized by hypersensitivity response, reversible airway obstruction and remodeling of the airways. Immunomodulatory activity of chlorogenic acid was investigated in ovalbumin (OVA)-induced allergic bronchial asthma in mice. The results showed that suppressed the hypersensitivity response, eosinophilia, expression of interleukin-4 (IL-4), interleukin-5, tumor necrosis factor-α (TNF-α) as well as total and ovalbumin-specific immunoglobulin E (Ig E). 
Using in vitro and in vivo models researchers proved that chlorogenic acid inhibied compound 48/80-induced systemic anaphylactic shock in mice and skin vascular permeability in rats. Chlorogenic acid also inhibited anti-dinitrophenyl (DNP) immunoglobulin E (IgE)- mediated passive cutaneous anaphylaxix (PCA). Moreover, depending on the dose, chlorogenic acid reduced histamine and (TNF-α) release from rat basophilic leukemia 2H3 (RBL2H3) cells. These results suggest that chlorogenic acid can be used in mast cell dependent allergic and anaphylactic reactions. 
Currently the popliteal lymphnode is considered a very promising tool for assessing immunosensitizing potential of low molecular weight compounds (LMWCs). In a study it was found that chlorogenic acid failed to induce immunoreactivity to some antigens. The study also showed that chlorogenic acid lacks the intrinsic capacity to stimulate or dysregulate immune responses to some antigens. 
In response to the controversies of published studies on the potential sensitization of chlorogenic acid, Mingbao Lin et al, analyzed 108 articles published from January 1979 to October 2012. They feel much of the data was not of high quality. More high quality research is necessary to declare the final conclusion regarding the use of chlorogenic acid in allergic disorders. 
Sepsis is a complex, multifactorial, rapidly progressive disease characterized by an overwhelming activation of immune system and the countervailing anti-inflammatory response. In a study chlorogenic acid suppressed progression of the sepsis. 
Chlorogenic acid increases the outer and plasma membrane permeability, resulting in the loss of barrier function, disruption of outer membrane leading to death of many microorganisms. Chlorogenic acid shows bacteriostatic activity. Chlorogenic acid has antibacterial activity against Escherichia coli.
In an in vitro study chlorogenic acid showed antibacterial activity against Bacillus cereus, Clostridium sporogenes, Micrococcus luteus, Escherichia coli, Staphylococcus aureus, Pseudomonas flourescens and Salmonella enterica. , 
Viral neuraminidases are implicated in viral replication. By blocking viral neuraminidases chlorogenic acid exerts antiviral activity against influenza and parainfluenza viruses. Therefore chlorogenic acid is used for the treatment viral infections of the upper respiratory tract and influenza. Recently intravenous injection of 100 mg/kg body weight of chlorogenic acid was found to alleviate influenza infection caused by H 1 N 1 and H 3 N 2 viruses. 
In a study chlorogenic acid and its compounds were shown to inhibit HepG2.2.15 cells and duck hepatitis virus. 
In China, 20 mg/kg body weight of chlorogenic acid was found to be effective for the treatment of Enterovirus 71 (EV 71) infection. In laboratory, human rhabdomysarcoma (RD) cells are used to diagnose enterovirus infection. In experimental study chlorogenic acid inhibited EV 71 2A transcription and translation in EV 71-infected RD cells. Chlorogenic acid inhibited secretions of IL-6, TNF- α, interferon (IFN-γ) and monocyte chemotactic protein (MCP-1) in EV 71-infected RD cells. 
Chlorogenic acid, by disrupting the structure of cell membrane of many pathological fungi, showed antifungal activity in vitro. The antifungal activity of chlorogenic acid did not show any hemolytic effect on human erythrocytes. Thus chlorogenic acid can be a future candidate for the development of new antifungal agent. 
Chlorogenic acid showed antifungal and anti-mycotoxigenic activities against Aspergillus flavus and Aspergillus ochraceus. 
Actions on Hematopoetic System:
4-tert-octylphenol (OP) is a chemical compound from the group of alkylphenols. The substance is estrogenic and belongs to the chemicals known as 'endocrine disruptors'. In animal studies, 4-tert-octylphenol (OP) induced significant pnacytopenia, decreased serum levels of sodium, potassium, chloride, calcium and phosphorus. OP reduces glutathione-S-transferase, glutathione peroxidase, glutathione reductase, catalase and superoxide dismutase. More over OP increased serum hepcidin, ferritin, transferrin, erythropoietin, aspartate aminotransferase, alanine aminotransferase, alkaline phosphatae, urea, creatinine, selenium, zinc, manganese, copper, iron, malondialdehyde and protein carbonyl levels. Treatment with chlorogenic acid corrected anemia, pancytopenia, mineral disturbances and restored all the disturbed levels to normal values. 
Chlorogenic acid promotes expression of caspase-3,-7,-8,-9 in U 937 cells. Chlorogenic acid induces cell death in U 937 leukemia cells through caspase dependent and mitochondria-dependent pathways. 
Actions on the Skin:
TPA (12-O-tetradecanoylphorbol-13-acetate) is used in cancer research to stimulate division of B-cells during cytogenic diagnosis of B-cell cancers such as chronic lymphocytic leukemia. Topical application of chlorogenic acid inhibits epidermal ornithine decarboxylase activity. Thus chlorogenic acid inhibits TPA (12-O-tetradecanoylphorbol-13-acetate) induced tumors. 
Actions on Musculo-skeletal System:
In female Sprague-Dawley rats at 27 and 45 mg/kg body weight per day chlorogenic acid inhibited the decrease of bone density caused by estrogen deficiency. Furthermore chlorogenic acid was found to promote proliferation of osteoblast precursors and subsequently differentiation of osteoblasts by inhibiting Shp-2 gene, phospho-Akt and cyclin D1. Thus chlorogenic acid can prevent osteoporosis. 
Actions on Endocrine System:
Chlorogenic acid modifies gastrointestinal (GI) hormone secretion and glucose tolerance. 
Actions on the Breast:
Chlorogenic acid belongs to phenolic acid group. It does exhibit group action. Its antiproliferative and apoptotic effects show anti-breast cancer activity. This effect is attributed to the antioxidant property of this compound on T47D human breast cancer cells. Chlorogenic acid does not interfere with steroid and adrenergic receptors. 
Action on Nervous system:
Chlorogenic acid is said to be present in human nervous tissue. Chlorogenic acid from decaffeinated green coffee is highly absorbed and metabolized in humans. Chlorogenic acid is used as a nutritional supplement. 
Chlorogenic acid has protective effect against cerebral ischemia. Depending upon the dose, Chlorogenic acid reduces the volume of infarct, sensory-motor functional deficit, reduces brain edema, reduces lipid peroxidation (LPO) and inhibits matrix metalloproteinase (MMP) expressions and activities. These effects of chlorogenic acid were due to its antioxidant and free radical scavenging activities. These results suggest that chlorogenic acid has protective effect against cerebral ischemia. 
Recent evidence suggests that consumption of chlorogenic acid in the diet protects the brain from neuro-degenerative changes. 
The activated microglia release pro-inflammatory factors in the brain. They contribute to the progression of neurodegenerative diseases. The anti-inflammatory activity of chlorogenic acid, by mediating microglial activation protects the brain from neuro- degenerative diseases. 
In mice chlorogenic acid exerted neuro-protective effect against scopolamine induced amnesia via improving antioxidant defense mechanism and by decreasing the activity of acetylcholine esterase. 
Chlorogenic acid and its metabolites evoke neurotrophic respone in hippocampal cells. 
Cadmium induces brain damage due to oxidative stress. Cadmium treated rats displayed numerous pathological changes in the brain such as inhibition of acetylcholinesterase, elevated lipid peroxidation, depletion of enzymatic and non-enzymatic antioxidants, reduction of membrane-bound ATPase activity, mitochondrial dysfunction and DNA fragmentation. Pretreatment of the rats with chlorogenic acid attenuated these ill effects induced by cadmium. This study suggests that chlorogenic acid is beneficial in the prevention of brain damage and neuropathy due to heavy metal poisoning. 
The most detrimental effects of alcohol (ethanol) exposure are the loss of neurones in the hippocampus and neocortex which may be related to the apoptosis and necrosis due to oxidative stress. By counteracting against oxidative stress chlorogenic acid prevents alcohol induced neurotoxicity. 
The activated microglia release pro-inflammatory factors in the brain. They might be responsible for tumorigenesis in the brain. Chlorogenic acid is potent inhibitor of microsomal glucose 6-phosphate translocase (G6PT). This process is thought possess cancer chemopreventive properties. A study showed that chlorogenic acid has the potential to regulate invasive brain tumor-derived glioma cells. 
Actions on CVS:
Chlorogenic acid increases the homocysteine level in the blood even in healthy persons which is detrimental to the heart. Homocysteine is a biomarker for cardiovascular disease. It is yet unclear whether chlorogenic acid merely increases the biomarker or it actually increases the cardiovascular risk. , 
Chlorogenic acid and its metabolites exert a potent anti-hypertensive effect. This effect is attributed to ferulic acid a metabolite of chlorogenic acid. Ferulic acid is vasodilator. , , 
Chlorogenic acid is vasodilator, reduces elevated blood pressure, attenuates endothelial dysfunction and improves endothelial function. Chlorogenic acid reduces oxidative stress and improves the bioavailability of nitric oxide in hypertensive subjects. 
Anti-inflammatory and antioxidant activities of chlorogenic acid protect endothelial cells of the human umbilical vein from the toxic damage induced by Perfluorooctane Sulphonate. 
Several research papers reported anti-hypertensive activity of chloroenic acid. To arrive at a definite scientific conclusion on this issue Onakpoya I J et al undertook a meta-analytical review. Five eligible studies including 364 patients were included. The meta-analysis also showed that chloroenic acid significantly reduced systolic and diastolic blood pressure. 
Antioxidant activity, better bioavailability of nitric oxide in arterial vasculature and improvement in endothelial function are the key factors for lowering of blood pressure by chlorogenic acid. Inclusion of chlorogenic acid in the diet may hold a promise for providing a non-pharmacological approach for the prevention and treatment of hypertension. 
Actions on RS:
A study was designed to evaluate protective effects of chlorogenic acid against lipopolysaccharide (LPS)-induced acute lung injury. The study group treated mice with chlorogenic acid at doses of 5, 20 and 50 mg/kg body weight 30 minutes or 3 hours after intra-tracheal administration of lipopolysaccharide (LPS). The histological study after the treatment with chlorogenic acid displayed reduction in edema, hemorrhage, vascularity and alveolar structural damage caused by lipopolysaccharide (LPS). At the dose of 50 mg/kg body weight chlorogenic acid protected mice from acute lung injury caused by lipopolysaccharide (LPS). 
Actions on the Pancreas:
Chlorogenic acid in decaffeinated coffee (green coffee) inhibited porcine pancreatic lipase. 
Actions on Liver:
Anti-inflammatory and antioxidant properties of chlorogenic acid protected the liver from carbontetrachloride (CCl4) induced hepato-toxicity in male Sprague-Dawley rats. Chlorogenic acid significantly attenuated the symptoms of liver inflammation and fibrosis induced by carbontetrachloride (CCl4). Chlorogenic acid also significantly reduced the elevated liver enzymes. The histological study also revealed improvement in the structure of the liver. This is attributed to inhibition of the activation of toll-like receptor 4 (TLR4/NF-κB) signaling pathway in the liver by chlorogenic acid. 
Methamphetamine intoxication can cause acute hepatic failure. If treated with chlorogenic acid before administration of methamphetamine chlorogenic acid can prevent hepatic injury. 
Hepatic ischemia-reperfusion is accompanied by excessive reactive oxygen species and hepatic inflammation. Chlorogenic acid has been shown to exert potent anti-inflammatory, antioxidant and antimicrobial activities. Thus chlorogenic acid might have potential as an agent for the treatment of hepatic ischemia-reperfusion injury. 
Chlorogenic acid suppresses the invasion of AH109A, a rat ascites hepatoma cell line at concentrations of 5-40 µM without altering the cell proliferation. Thus in future chlorogenic acid can be an important chemical for the treatment of hepatoma. 
5-fluorouracil (5-FU) inhibits proliferation of heptocellular carcinoma cells. Chlorogenic acid enhances the effects of 5-fluorouracil. Chlorogenic acid acts as a chemosensitizer of 5-fluorouracil in the treatment of hepatocellular carcinoma. This activity is attributed to inhibition of extracellular signal-regulated kinases by chlorogenic acid 
Actions in Diabetes:
Chlorogenic acid lowered blood sugar in streptozotocin-induced diabetic rats. Chlorogenic acid also improved memory, prevented neuropathy and improved acetylcholine esterase (AChE) activity in streptozotocin-induced diabetic rats. 
Diabetic rats treated with chlorogenic acid showed an increase in adenosine monophosphate hydrolysis in cerebral cortex. Furthermore chlorogenic acid also reduced the platelet aggregation in the brain. 
AMPK (5' adenosine monophosphate-activated protein kinase) is an enzyme that plays an important role in cellular energy homeostasis. The net effect of AMPK activation is stimulation of activation of hepatic fatty acid oxidation, ketogenesis, stimulation of skeletal muscle fatty acid oxidation and glucose uptake; inhibition of cholesterol synthesis, triglyceride synthesis, lipogenesis, inhibition of adepocyte- lipolysis and modulation of insulin secretion by pancreatic beta-cells. Chlorogenic acid stimulates glucose uptake in skeletal muscle through activation of 5' adenosine monophosphate-activated protein kinase (AMPK). , , 
Disorders of glucose metabolism and lipid metabolism are closely related. They may result into diabetes, obesity, hypertension, hepatic steatisis, cardiovascular disease, neuropathies and cancer. Chlorogenic acid can prevent these events. 
Chlorogenic acid has a significant effect on the absorption and utilization of glucose. Use of chlorogenic acid for an extended time may reduce body fat and body mass.
A study on high fat-fed mice showed that, chlorogenic acid improved body weight, lipid metabolism and levels of obesity-related hormones in high-fat fed mice. Chlorogenic acid seemed to be more potent for body weight reduction and regulation of lipid metabolism than caffeic acid. , , 
To assess the effects of chlorogenic acid on lipid metabolism in male golden hamsters, the animals were fed on 15% high fat diet. The animals were treated with chlorogenic acid 80 mg/kg body weight for eight weeks. The results of the treatment showed that the levels of fasting serum triglyceride (TG), free fatty acid (FFA), total cholesterol (TC), low density lipoprotein cholesterol (LDL) glucose and insulin were significantly lower. Chlorogenic acid also led to higher activity of hepatic lipase (HL), lower contents of TG (triglyceride) and FFA (free fatty acid) in the liver. Thus chlorogenic acid can modify lipid and glucose metabolism , 
Actions on Reproductive System:
In the only reported rat study, chlorogenic acid at 5-500 mg/kg body weight per day induced rib defects in fetuses of 5-12 weeks of gestation. No CNS defects and fetal or maternal mortality was reported. 
Chlorogenic acid can prevent lung cancer. Chlorogenic acid induces high levels of topoisimerase I- and topoisomerase II-DNA complexes in cells. This is responsible for anticancer activity of chlorogenic acid. The lung cancer cells (A549) are more sensitive than normal lung fibroblasts (MRC5) to chlorogenic acid. This and the findings from some other studies suggest that the cytotoxic activity of chlorogenic acid may be selective in killing cancer cells. 
In a study, treatment of adenocarcinoma cells of colon with chlorogenic acid and neochlorogenic acid at concentrations of 150-500 µmol significantly reduced cell proliferation. The cell morphology of treated cells changed: the surface of cells became uneven, more rough and irregular in shape. These changes were dependent on the concentrations used. 
Chlorogenic acid is able to change gene expression involved in immunepathways. Chlorogenic acid promotes the activation and proliferation of T cells,macrophages and natural killer cells. Thus by enhancing killing abilities of these cells, chlorogenic acid can suppress the growth rate of tumor cells. 
Chlorogenic acid upregulates glycogen synthase kinase 3 (GSK-3β) and antigen-presenting cell (APC) genes which could inhibit free β-catenin into the nucleus. This disrupts the cell proliferation and causes apoptosis of cancer cells. 
Toxicity of Chlorogenic acid:
High intake of chlorogenic acid could be responsible for the higher homocysteine concentration in the blood. This can be a risk for cardiovascular diseases. 
Dose: 120-300 mg for oral intake 
Molecular formula: C9H8O2 (C6H5CHCHCO2H)
Cinnamic acid is a white crystalline organic compound, slightly soluble in water, and freely soluble in many organic solvents. It is classified as an unsaturated carboxylic acid. It occurs naturally in a number of plants.
Cinnamic acid is obtained from oil of cinnamon or from balsams such as storax. Cinnamic acid has a honey like odor. In pharmaceuticals it is a popular flavoring agent.
Cinnamic acid in its pure form is a precursor of famous sweetener aspartame.
[Note: Aspartame is widely used as an artificial sweetener. Upon ingestion it produces methanol as a metabolite which is subsequently converted into formaldehyde and formate. Both are hepatotoxic and carcinogenic. Terefore Cinnamic acid should be used with caution] , 
After oral administration cinnamic acid is quickly absorbed in stomach and intestine. It is completely metabolized in the liver before it is absorbed in the blood and is excreted in urine. 
Cinnamic acid is not used as a medicine or a drug. Derivatives and esters of cinnamic acid have anti-inflammatory, antioxidant and cytotoxic properties. They are lipooxigenase inhibitors. Some derivatives and esters are tested for anticancer activities. 
Cinnamic acid derivatives especially those with phenolic hydroxyl group are strong antioxidants. They have several health benefits. They show anti-inflammatory, antioxidant, antibacterial, antiviral, antifungal properties. 
Like cinnamic acid, its derivative 7-O-Cinnamoylmorroniside exhibits a strong anti-inflammatory activity. E-selectin, also known as CD62 antigen-like family member E (CD 62 E) is a cell adhesion molecule expressed only on endothelial cells activated by cytokines. E-selectin plays an important role in inflammations. Cinnamoylmorroniside is a potent inhibitor of tumor necrosis factor alpha (TNF-α)- induced expression. 
Derivatives of cinnamic acid show higher antioxidant activity than that of cinnamic acid. This is due to the presence of vinyl fragments. This property of the derivatives attracts attention of pharma industry for the development of new drugs especially for the treatment of pathologies related to lipid peroxidation in cellular membranes. 
Cinnamic acid derivatives especially those with phenolic hydroxyl group are strong antioxidants. They have several health benefits. They show anti-inflammatory, antioxidant, antibacterial, antiviral, antifungal properties. 
Most of the cinnamic acids, their esters, amides, aldehydes and alcohols show significant inhibition of growth of several bacterial and fungal species. The data of antimicrobial species is however inadequate. The search is on to develop antitubercular drug with hybrids between cinnamic acids and biologically active other antimicrobial compounds. 
Recently a series of esters, substituted derivatives and amides of cinnamic acid were synthesized. They showed antibacterial activity against Gram negative organisms. They were especially effective against Escherichia coli and the fungus Candida albicans. 
Cinnamic acid, trans-cinnamic acid and derivatives of cinnamic acid exhibit antiviral activity against many viruses. They are not virucidal but inhibit the replication cycle of viruses 
In a study Kim JH et al found antifungal activity of cinnamic acid and its derivatives. Of these 4-chloro cinnamate showed highest antifungal activity against C. rolfsii. 
Cinnamic acid and its derivatives inhibit the transport of monocarboxylate across erythrocyte and mitochondrial membranes. They also inhibit parasite growth and are effective at ring and trophozoite stages of the malarial parasite. Antimalarial activity of cinnamic acid could be due to inhibition of lactate transport or of mitochondrial respiration. Since cinnamic acid and its derivatives are also noxious to host cells they cannot be used to develop novel anti-malarial drugs. However they are useful tools in research. 
Actions on the skin:
By causing irreversible damage to DNA leading to cell death, cinnamic acid and its derivatives induce apoptosis in human melanoma cells. In a study, human melanocyte cell line (HT-144) and human melanocyte cell line derived from blue nevus (NGM) were exposed to cinnamic acid. HT-144 cells were sensitive to cinnamic acid treatment while NGM cells were less sensitive. The cell death was due to aberrations caused in DNA leading to non-viability of cells. This study showsthat cinnamic acid has effective antiproliferative activity against melanoma cells. Further study is necessary to develop anticancer drugs from cinnamic acid. 
Actions on CNS:
Fourteen derivatives of cinnamic acid were tested for their effects on central nervous system. All of them prolonged the sleep induced by phenobarbitone. This shows that cinnamic acid derivatives are central nervous system depressants. 
To evaluate effects of cinnamic acid and its derivatives, experiments were performed on slices of rat brains of either sexes. Increase in the concentration of potassium ions results in the increases in the oxygen uptake by respiring slices of cerebral cortex. Cinnamic acid and its derivatives suppressed the potassium activated oxygen uptake in brain slices. 
Halogenated cinnamic acid derivativives show highest CNS depressant activity. 
Actions on CVS:
Cinnamic acid and its derivatives viz. 3, 4-dihydrocinnamate i.e. L-serine methyl ester and L-aspartic acid show lipid lowering property. By using clofibrate as a positive control Kim and co-workers reported that cinnamic acid derivatives lowered atherogenic index and increased serum HDL. The derivatives also lowered hepatic cholesterol.
By inhibiting human acetyl-Co A, cellular cholesterol storage and LDL-oxidation these derivatives prevent atherosclerosis. 
Actions on RS:
A series of novel cinnamic acid derivatives was synthesized. They suppress the growth of A 549 lung cancer cells effectively. 
Actions on GI System:
Trans-cinnamic acid (tCA) was observed to inhibit the proliferation of colon carcinoma cells. No toxic changes were found in the heart, lung, colon, liver, kidney or bone marrow following histopathological examination. 
Recently cinnamyl sulphonamide hydroxamate, a novel derivative of cinnamic acid has been synthesized. Histone deacetylases (HDAC) are a group of enzymes that regulate DNA expression. The hydroxamate derivatives of cinnamic acid are inhibitors of HDAC enzyme. By acting through HDAC enzyme inhibition hydroxamate derivatives of cinnamic acid act against adenocarcinoma of the colon. 
Actions on the Liver:
Trichlorfon is hepatotoxic, mutagenic pesticide. Cinnamic acid at 30 and 60 mg/kg body weight protects the liver against toxicity caused by trichlorfon. Cinnamic acid can cure trichlorfon-induced hepatotoxicity. 
Pre-treatment with cinnamic acid at 2.8 mg/kg body weight was found to protect the liver against mutagenic effects of cyclophosphamide. Cinnamic acid also reversed the hepatocyte damage caused by cyclophosphamide treatment. 
At 20 mg/kg body weight, cinnamic acid protects the liver from cisplatin-induced hepatotoxicity. Therefore cinnamic acid can be considered to be considered to be a potential candidate for hepato-renal protection against cisplatin-induced toxicity. 
At 28 and 56 mg/kg body weight cinnamic acid protects the liver from acute hepatocyte damage caused by endoxan. This activity is much superior to protection offered by vitamin C. Cinnamic acid even prevents the necrosis of hepatocytes caused by endoxan. 
Actions on Metabolism/ Obesity:
Obesity is a chronic metabolic and proinflammatory disorder associated with hyperlipidemia (dyslipidemia), diabetes mellitus, hypertension, atherosclerosis, ccardiovascular disease, non alcoholic fatty liver disease, nephropathy and cancer. In experimental studies on animal models, cinnamic acid at 30 mg/kg body weight for 7days, normalized the body weight in high fat diet fed animals, lipid profile reverted back to normal levels the activities of lipase and angiotensin converting enzyme. Cinnamic acid also prevented the vasoconstriction of aorta as evidenced on echocardiography. Cinnamic acid also prevented the steatosis of the liver. 
Cinnamates and various other derivatives of cinnamic acid such as compound b and c also lower the raised lipid levels in plasma as does cinnamic acid. Whereas cinnamic acid lowered hepatic-HMG-CoA reductase activity, its synthetic derivatives (a and b) do not affect hepatic-HMG-CoA reductase activity 
Protein Tyrosine Phosphatase 1B (PTP1B) inhibitors are much sought after drugs for the treatment of type 2 diabetes and obesity. Cinnamic acid and its derivatives (o-Hydroxycinnamic acid 25 µM and p-Hydroxycinnamic acid 25 µM) being PTP1B inhibitors are useful for the treatment of type 2 diabetes and obesity. 
A series of cinnamic acid derivatives were synthesized. They inhibit LDL-oxidation, acyl-Co A cholesterol acyltransferase-1 and-2 activities. Thus cinnamic acid derivatives are useful as anti-atherosclerotic agents 
Cinnamic acid derivatives show strong hypoglycemic activity. 
At doses of 40-100 mg/kg body weight, by stimulating insulin secretion from the β cells of the pancreas p-methoxycinnamic acid lowers blood sugar in normal and streptozotocin-induced diabetic rats. 
Cinnamic acid derivatives show insulin releasing properties. 
By increasing calcium influx via L-type calcium channels p-methoxycinnamic acid stimulates insulin secretion from the β cells of the pancreas but not through the closure of ATP-sensivive K-channels.
Furthermore based on several in vitro studies researchers found that cinnamic acid and its derivatives act on different mechanism of actions including stimulation of beta cells to secrete insulin, improving the function of beta cells of the pancreas, increased insulin signaling pathway, inhibition of hepatic gluconeogenesis, enhanced glucose uptake, delay of carbohydrate digestion and glucose absorption and inhibition of protein glycation. However bioavailability of cinnamic acid and its derivatives is low and not much study has been done on human subjects. Therefore these useful agents have limited use in clinical practice. , 
Hydrocinnamic acid derivatives act as supplements to other conventional oral hypoglycemic agents and may reduce the secondary complications caused by oral hypoglycemic agents. 
Actions on Male Reproductive system:
Cinnamic acid and its derivatives have higher affinity for α 1 A-adrenoceptors. Researchers are investigating their role and importance in benign hyperplasia of prostate. 
Products derived from cinnamic acid such as cinnamoyl acid, esters, amides, hydrazides and related derivatives show cytotoxic and antitumor activity. 
Cinnamic acid and its derivatives have inspired researcher to design inhibitors of oncogenic protein kinases. The mode of inhibition may vary from ATP-competitive to non-competitive one. 
Analogues of cinnamic acid benzyle amide exhibit pleiotropic effects on cancer cells. 
Cynnamic acid and its derivatives induce cell cycle arrest in cancer cell lines 
Cinnamyl sulphonamide hydroxamate derivatives (HDAC) inhibitors show anti-angiogenic, anti-cancer and anti-metastatic activities in human cancer cells. 
Toxicity of cinnamic acid:
Cinnamic acid is a compound of low toxicity. Its compounds aldehyde, alcohol, esters and those containing cyano and fluoro moieties are more toxic. 
Molecular formula: C9H8O3
O-Coumaric acid is a hydroxycinnamic acid. There are three isomers of coumaric acid: o-coumaric acid, m-oumaric acid and p-coumaric acid. p-coumaric acid is the most abundant isomer of the three in the nature. They are slightly soluble in water but well soluble in ethanol and diethyl ether.
O-Coumaric acid can be found in vinegar. 
O-coumaric acid is antioxidant and is useful in the treatment of obesity and diabetes.
Christambine are crystalline compounds of embolic acid with soda, potash and ammonia. They are alkaloids and pharmacologically act as alkaloids. 
Molecular formula: C35H60O6
Daucosterol aka Elutheroside A is a natural phytosterol-like compound. It is the glucoside of β-sitosterol.
Daucosterol exhibits many properties similar to β-sitosterol.
Daucosterol promotes the proliferation of neural stem cells.
Daucosterol is used by athletes to build up stamina.
A study shows that daucosterol is an efficient and inexpensive growth factor that could be used in clinical medicine and research applications. , 
Some testimonials from modern research
Pharmacology, toxicity, dosages etc of each phytochemical contained in Widanga (Embelia ribes) have been discussed in detail above. The pharmacological actions of Widanga (Embelia ribes) therefore are a collective action of all the phytochemicals contained in it.
1. Syed Asadulla, Ramandang, Rajasekharan; PHARMACOGNOSY OF EMBELIA RIBES BURM F, IJRPC 2011, 1(4); ISSN: 2231-2781
2. http://www.biodiversityofindia.org/index.php?title=Embelia ribes
3. M. Mhaskar et al, Status of Embelia ribes Burm f. (Vidanga), an important medicinal species of commerce from northern Western Ghats of India, Current Science, Vol. 100, No. 4, 25 February, 2011
4. Ravikumar K et al, Illustrated Field Guide of 100 Red Listed Medicinal Plants of Conservation Concern in Southern India, Foundation for Revitalization of Local Health Traditions, Bangalore, India
5. Patwardhan A et al, Popagation and Cultivation Techniques of Embelia ribes (Vidanga), Daya Publishing House, New Delhi 237-256
6. The Ayurvedic Pharmacopoeia of India part 1, Vol. 1
8. Bharat Lal and Neeraj Mishra, Importance of Embelia ribes: AN UPDATE, International Journal of Pharmaceutical Sciences and Research, Projected Impact Factor (2015) 1.11, 90.24
9. Syed Asadulla, Ramandang, Rajasekharan, PHARMACOGNOSY OF EMBELIA RIBES BURM F; IJRPC 2011, 1(4); ISSN: 2231-2781
10. google images
11. MV Sudhakaran, Botanical Pharmacognosy of the Fruit of Embelia ribes Burm. F, Journal of Pharmacognosy and Natural Products, September 28, 2015
12. Harish G. U. et al, Endangered Medicinal Plant Embelia ribes Burm. f- A Review, Pharmacognosy Journal, Vol. 4, Issue 27, Jan-Feb 2012.
13. The Ayurvedic Pharmacopoeia of India Part I, Volume I
15. google images
16. Endangered Medicinal Plant Embelia ribes Burm.f.- A Review Harish G.U., Vijay Danapur, Renuka Jain and Villoo Morawala Patel Avesthagen Limited, Discoverer, 9th Floor, International Tech Park, White Field Road, Bangalore-560066, INDIA Submission Date: 16-9-2011; Review completed: 31-10-2011; Accepted Date: 26-11-2011
17. The Ayurvedic Pharmacopoeia of India Part I, Volume I
18. Sudni RJ, Akbari BV, G. Vidyasagar; Pharmacognostical and Preliminary Phytochemical Investigation of Embelia ribes Burm f; International Journal of Pharmaceutical and Biological Archives 2011; 2(2):648-651
19. Harish G. U. et al, Endangered Medicinal Plant Embelia ribes Burm. f- A Review, Pharmacognosy Journal, Vol. 4, Issue 27, Jan-Feb 2012.
20. Warrier PK et al, Some Important Medicinal Plants of the Western Ghats, India: a Profile; International Development Research Centre (IDRC) Canada 2001, 139-156
22. Srinath Ambati, Jyothi V, Asha Jyothi; Pharmacological, Pharmacognostic and Phytochemical Review of Embelia ribes; www.ijptonline.com; 09-11-2010
23. The Ayurvedic Pharmacopoeia of India Part 1, Volume 1.
24. Harish G. U. et al, Endangered Medicinal Plant Embelia ribes Burm. f- A Review, Pharmacognosy Journal, Vol. 4, Issue 27, Jan-Feb 2012.
25. Warrier PK et al, Some Important Medicinal Plants of the Western Ghats, India: a Profile; International Development Research Centre (IDRC) Canada 2001, 139-156
26. The Ayurvedic Pharmacopoeia of India Part 1, Volume 1.
27. Quentin B. Zielinski, Chromosome Numbers and Meiotic Studies in Ribes, International Journal of Plant Sciences, Volume 114, Number 3, March 1953
28. Sabitha Rani A and Nagamani V, Genetic Diversity Analysis in Embelia ribes by RAPD markers, International Journal of Medical and Health Sciences, Volume 3, No. 6, 2016
29. Devaiah M Kambiranda and Padma Venkatasubramanian, Genetic Characterization and authentication of Embelia ribes using RAPD-PCR markers, Planta Medica 74(2): 194-196; March 2008
30. The Ayurvedic Pharmacopoeia of India Part 1, Volume 1.
31. Bharat Lal and Neeraj Mishra, Importance of Embelia ribes: An Update, International Journal of Pharmaceutical Sciences and Research; 2015, 90.24
35. The Ayurvedic Pharmacopoeia of India Part 1, Volume 1.
39. Syed Asadulla, Ramandang, Rajasekharan, PHARMACOGNOSY OF EMBELIA RIBES BURM F; IJRPC 2011, 1(4); ISSN: 2231-2781
40. M. Mhaskar, S. Joshi, B. Chavan, A. Joglekar, N. Barve, A. Patwardhan; Status of Embelia ribes Burm f. (Vidanga); an important medicinal species of commerce from northern Western Ghats of India, CURRENT SCIENCE, VOL. 100, NO. 4, 25 FEBRUARY 2011
42. Galvina M. Ferreia, Kirti S. Loddha, Histochemical Localization of Embelin in fruits of Embelia ribes Burm and its quantification (2013)
44. Embelin and its role in chronic diseases/https://books.google.co.in/books?
45. Maulik Suthar et al, Screening Embelia ribes for antifungal activity, International Journal of Pharmaceutical Sciences and Drug Research, 2009; 1(3): 203-206
46. CPS McErlean, CJ Moody, First synthesis of N-(3-carboxyl)-5amino-2-hydroxy-3-tridecyl-1, 4-benzoquinone, an unusual quinone isolated from Embelia ribes, The Journal of organic chemistry 2007.
47. M Chitra et al, Anti-tumor, Analgesic and analgesic Property of Embelin, A Plant Product, Chemotherapy 1994; 40: 109-113
48. Mahendran S et al, Synthesis and evaluation of analgesic and anti-inflammatory activities of most active free radical scavenging derivatives of embelin-A structure-activity relationship, Chem Pharm Bull (Tokyo) 2011; 59(8): 913-919
49. Dhanial JK et al, Embelin inhibits TNF- α converting enzyme and cancer cell metastasis: molecular dynamics and experimental evidence' BMC Cancer, 2014 oct 22; 14, 775.
50. Joshi R et al, Free radical scavenging reactions and antioxidant activity of embelin: biochemical and pulse radiolytic studies, Chemical Biology Interact 2007; 167: 125-134
52. Dharmendra Singh et al, Effects of Embelin on Lipid Peroxidation and free Radical Scavenging Activity against Liver damage in Rats, Journal compilation 2009 Nordic Pharmacological Society. Basic Clinical Pharmacology & Toxicology, 105, 243-248
53. Tambekar D. H. et al, Screening of antibacterial potentials of some medicinal plants from Melghat forest in India. Afr.J. Trad. Complementary and Alternative Medicines 2009; 6: 228-232
54. Umang H et al, International Journal of Pharma Tech Research 2009; 1: 1594-1597.
55. Chitra M, et al, Antibacterial activity of embelin. Fitoterapia 2003; 74:401-403
56. Radhakrishnan N et al, A potential antibacterial agent Embelin, a natural benzoquinone extracted from Embelia ribes, Research Article Biology and Medicine, Vol 3 (2) Special Issue:1-7, 2011
57. Rani P, Khullar N, Antimicrobial evaluation of some medicinal plants for their anti-enteric potential against multi-drug resistant Salmonella typhi, Phytotherapy Research 2004 Aug; 18(8): 670-673
58. Arushdeep Sidana et al, Isolation and Biotransformation and evaluation of Antibacterial activity of embelin from Embelia ribes, UJPAH, Vol II, No. 13, Dec. 2012
59. Malvika Saini, Gaurav Sharma, Mita Kotecha, A comparative Antimicrobial Evaluation of Embelia ribes Burm. f. and Embeliaro Busta auct. Nonroxb. Fruits, International Journal of Pharmaceutical Sciences and Research, 2015; 1, 11: 90.24
60. Daniel Bisrat et al, In vitro Antibacterial activity of a Semi-synthetic Derivative of Embelin, Ethiopian Pharmaceutical Journal 30 (01): 50-56; June 2014
61. Rosalyn Pena et al, Multicomponent Synthesis of Antibacterial Dihydropyridin and Dihydropyran Embelin Derivatives, The Journal of Organic Chemistry, 2013; 78 (16), pp 7977-7985
62. Maulik Suthar et al, Screening of Embelia ribes for antifungal activity, International Journal of Pharmaceutical Sciences and Drug Research, 2009; 1(3): 203-206
63. Rani AS et al, In vitro evaluation of of Antifungal Activity of the Seed Extract of Embelia ribes, Indian J Pharm Sci 2011 March; 73(2): 247-249
64. John Martin Honigberger, Thirty-five years in the East, Volume II, Edited by H Bailliere (London) 1852.
65. Watt GA, A Dictionary of Economic Products of India, Volume 3, Cosmo Publication, New Delhi, India, Reprinted 1972
66. Padma Venkatsubramanian, Ashwini Godbole, R. Vidyashankar and Gina R Kuruvilla, Evaluation of traditional anthelmintic herbs as substitutes for the endangered Embelia ribes, using Caenorhabditis elegans model, Current Science Vol. 105, No. 11, 10 December 2013
67. Jalapure SS et al, In vitro anthelmintic property of various seed oils against Pheritima posthuma, Indian J Pharm Sci 2007; 69: 158-160
68. Anonymous. Herbal monograph-Embelia ribes, 2002, www.himalayahealthcare.com/herbfinder/h_embelin.htm
69. Gabriela Egly Feresin, Bioactive alkyl phenols and embelin from Oxalis erythrorhiza, Journal of Ethnopharmacology, Volume 88, Issue 2-3, October 2003, Pages 241-247
70. TRP Kekuda, In vitro anthelmintic activity of aqueous extract of Embelia ribes,
71. GP Choudhary, Anthelmintic activity of Embelia ribes Burm. International Journal of Pharmaceutical and Chemical Sciences Vol.1 (4) Oct-Dec 2012
72. Mojumdar V, Mishra SD, In vitro studies on toxicity of embelin and its haloderivatives to Meloidogyne incognita juveniles. Curr Nematol 1990; 1: 47-48
73. Kibrnesh Benzu, In vivo Antimalarial Evaluation of Embelin and Some Semi-Synthetic Aromatic Amine Substituted Embelin Derivatives from the fruit of Embelia schimperia, etd.aau.edu.et
74. Effect of Vasicine, Vasinone and Embelin on Some Important Rargets of Plasmodium falciparium, shodhganga.inflibnet.ac.in/10603/1379/11/11_chapter6.pdf
75. O. I. Zaid et al, Antiplasmodial and chloroquine resistance effects of embelin, Pharmacognosy Magazine, 13 (49), S 48-S 55.
76. G. Kalyan Kumar, Embelin reduces cutaneous TNF-α level and ameliorates skin edema in acute and chronic model of skin inflammation in mice, European Journal of Pharmacology, Volume 662, Issue 1-3, 15 July 2011, Pages 63-69
77. H. M. Kumar Swamy et al, Wound healing activity of embelin isolated from the ethanol extract of leaves of Embelia ribes Burm. Journal of Ethnopharmacology, Volume 109, Issue 3, 12 February 2007, Pages 529- 534
78. Reuter S et al, Embelin suppresses the osteoclastogenesis induced by receptor activator of NF-κB ligand and tumor cells in vitro through inhibition of the NF-κB cell signaling pathway, Mol Cancer Res. 2010 Oct; 8 (10): 1425-1436
80/ Young Heo, Embelin suppresses STAT 3 signaling, proliferation and survival of multiple myeloma via the protein tyrosine phosphatase PTEN, Cancer Letters, Volume 308, Issue 1, 1 September 2011, Pages 71-80
82. Y Sun et al, Elevated cell proliferation and VEGF production by high-glucose conditions in Muller cells involve XIAP; Eye 2013 27; 1299-1307. Published on line 9 August 2013
83. Yang Li et al, Embelin-indiced MCF-7 breast cancer cell apoptosis and blockade of MCF-7 cells in G2/M phase via the mitochondrial pathway, Onchology letters,https://www.spandidos-publications.com/ol/5/3/1005; Dec 19, 2012
84. Jennifer L et al, XIAP Inhibition and Generation of Reactive Oxygen Species Enhances TRAIL Sensitivity in Inflammatory Breast Cancer Cells, Molecular Cancer Therapeutics 11 (7); July 2012, Published on line first 16 April 2012
85. W-J Lu, Mortalin-p53 interaction in cancer cells is stress dependent and constitutes a selective target for cancer therapy, Cell Death Differ. 2011 Jun; 18(6): 1046-1056
86. Nupur Nigam et al, Targeting Mortalin by Embelin Causes Activation of Tumor Suppressor p53 and Deactivation of Metastatic Signaling in Human Breast Cancer Cell, PLoS One, 2015; 10(9): e0138192
87. Gupta OP et al, Some pharmacological investigations of embelin and its semi-synthetic derivatives, Indian Journal of Physiology and Pharmacology, 01 Jan 1977, 21(1): 31-39
88. Uday P Kundap et al, Plant Derived Phytocompound Embelin in CNS Disorders: A Systematic Review, Fronttiers in Pharmacology; 2017; 8: 76
89. Z Xue et al, Embelin suppresses Dendritic Cell functions and Limits Autoimmune Encephalitis Through the TGF-β/β-catenin and STAT3 Signaling Pathways, Mol Neurobiol 21 Nov 2013; 49(2): 1087-1101
90. Atal CK et al, Non-narcotic orally, centrally acting analgesic from an Ayurvedic drug, J. Ethnopharmacol 1984; 11: 309-317
91. Zutshi U et al, Possible interaction of potassium embelate, a putative analgesic agent, with opiate receptors, Indian Journal of Experimental Biology 1989; 27: 656-657
92. Jalgon D E and Palayo F, Medicinal chemistry advances, edited by F G De Las Heras and S Vega, Pergamon press, New York 1980: 191
93. Muhammad Afzal et al, Evaluation of anxiolytic activity of embelin isolated from Embelia ribes, Biomedicine and Aging Pathology Volume 2 Pages 45-47; April 2012
94. Gaurav gupta et al, Anti-depressant like activity of Embelin isolated from Embelia ribes, Phytopharmacology 2013, 3(1): 87-95
95. Durg S et al, Antipsychotic activity of embelin isolated from Embelia ribes: A preliminary study, Biomed Pharmacother, 2017 Jun; 90: 328-331
96. Mahendran S et al, Anticonvulsant activity of embelin isolated from Embelia ribes, Phytomedicine, 2011; 15: 186-194
97. Shaikh A et al, Effect of embelin Against Liposaccharide-induced Sickness Behaviour in Mice, Phytother Res. 2016 May; 30 (5): 815-822.
98. Uday P Kundap et al, Plant Derived Phytocompound Embelin in CNS Disorders: A Systematic Review, Fronttiers in Pharmacology; 2017; 8: 76
99. Tippeswamy BS et al, Protective effect of embelin from Embelia ribes Burm. against transient global ischaemia-induced brain damage in rats, Neurotox Res. 2011 Nov; 20(4): 379-386
100. Uday P Kundap et al, Plant Derived Phytocompound Embelin in CNS Disorders: A Systematic Review, Fronttiers in Pharmacology; 2017; 8: 76
101. Dhadde SB et al Effect of embelin against 3-nitropropionic acid-induced Huntington's disease in rats, Biomed Pharmacother, 2016 Feb; 77: 52-58
102. Uday P Kundap et al, Plant Derived Phytocompound Embelin in CNS Disorders: A Systematic Review, Fronttiers in Pharmacology; 2017; 8: 76
103. Siegelin MD, Gaiser T, Siegelin Y, The XIAP inhibitor Embelin enhances TRAIL-mediated apoptosis in malignant glioma cells by down-regulation of the short isoform of FLIP, Neurochemistry International, Volume 55, Issue 6, November 2009; 423-430
104. Park SY et al, Embelin induces apoptosis in human glioma cells through inactivating NF-κ B, J Pharmacol Sci. 2013; 121(3): 192-199
105. Sahu BD et al, Cardioprotective effect of embelin on isoproterenol-induced myocardial injury in rats: possible involvement of mitochondrial dysfunftion and apoptosis, Life Sci. 2014 June 27; 107(1-2): 59-67
106. Zhao ZG et al, Protective effects of embelin on myocardial ischaemia-reperfusion injury following cardiac arrest in a rabbit model, Inflammation, 2015 Apr; 38(2): 527-33
107. https://www.researchgate.net/221982262_Preventive_Effect_of_Embelin_Embelia ribes
108. Shirole RL, Shirole NL, Saraf MN, Embelia ribes ameliorates lipopolysachharide-induced acute respiratory distress syndrome, J Ethnopharmacol 2015 Jun 20; 168: 356-363
109. DR Avisethi et al, Activation of p38/JNK pathway is responsible for embelin induced apoptosis in lung cancer: transitional role of reactive oxygen species, PLOS ONE, www.plosone.org, January 2014, Volume 9, Issue 1, e 87050
110. Sushil Gupta et al, Effects of embelin, a male antifertility agent, on absorptive and digestive functions of rat intestine, Journal of Ethnopharmacology, Volume 33, Issue 3, July 1991, Pages 203-212
111. BS Thippeswamy, Protective effect of embelin against acetic acid induced ulcerative colitis in rats, European journal of Pharmacognosy, Volume 654, Issue 1, 1 March 2011, pages 100-105
112. Kalyan Kumar G, Embelin ameliorates dextran sodium sulfate-induced colitis in mice, International Immunology, Volume 11, Issue 6, June 2011, Pages 724-731
113. Mori T et al, Effect of the XIAP inhibitor Embelin on TRAIL-induced apoptosis of pancreatic cancer cells, J Surg Res 2007 Oct; 142 (2): 281-286
114. Dharmendra Singh et al, Effects of embelin on Lipid Peroxidation and Free Radical Scavenging Activity against Liver Damage in Rats, Basic and Clinical Pharmacology, 26 May, 2009
115. Radhika Poojari et al, Chemoprotective and Hepatoprotective Effects of Embelin on N-Nitrosodiethylamine and Carbon Tetrachloride Induced Preneoplasia and Toxicity in Rat Liver, Asian Pacific Journal of Cancer Prevention, Volume 11, 2010
116. N Ghosh et al, Recent advances in herbal medicine for treatment of liver diseases, Pharmaceutical Biology, Volume 49, Issue 9, 2011
117. Jaspreet Kaur Dhanjal et al, Embelin inhibits TNF-α converting enzyme and cancer cell metastasis: molecular dynamics and experimental evidence, BMC Cancer 2014; 14: 775
118. Wehrkamp CJ et al, XIAP antagonist embelin inhibited proliferation of cholangiocarcinoma cells, PLoS One, 2014 Mar 6; 9(3): e90238
119. Sreepriya M and Geetha Bali, Chemopreventive effects of embelin and curcumin against N-nitrosodiethylamine/phenobarbital- induced hepato-carcinogenesis in Wistar rat, Fitoterapia, 2005; 76: 549-555
120. HS Chaudhari et al, Preventive Effect of Embelin from Embelia ribes on Lipid Metabolism and Oxidative Stress in High-Fat-Diet-Induced Obesity in Rats, Planta Med 78(7), 651-657; 2012 Mar 26
121. Naik SR et al, Anti-diabetic activity of embelin: involvement of cellular inflammatory mediators, oxidative stress and other biomarkers, Phytomedicine, 2013 July 15; 20(10): 797-804.
122. S. Mahendran et al, Evaluation of anti-diabetic effect of embelin from Embelia ribes in alloxan induced diabetes in rats, Biomedicine & Preventive Nutrition, Volume 1, January-March 2011, Pages 25-31
123. Gandhi GR et al, Insulin sensitization via a partial agonism of PPAR γ and glucose uptake through translocation and activation of GLUT4 in PI3K/p-Akt signaling pathway by embelin in type 2 diabetic rats, Biochem Biophys Acta 2013 Jan; 1830(1): 2243-2255
124. Gupta R, Antioxidant activity and protection of pancreatic β cells by embelin in streptozotocin-induced diabetes, J Diabetes, 2012 Sep; 4(3):248-256
125. Ashish K Sahu et al, Effect of embelin on lithium-induced nephrogenic diabetes insipidus in albino rats, Asian Pacific Journal of Tropical Diseases 2013, S729-S733
126. Krishnaswamy and Purushothaman, Antifertility properties of Embelia ribes, Ind. J. Exp. Biol 1980; 1359-1360
127. Gupta S et al, Antispermatogenic effect of embelin, a plant benzoquinone, on male albino rats in vivo and in vitro, Contraception 1989; 39: 307-320
128. MN Mungai, Optimizing The Dose Of Embelin, A Potential Male Antifertility Agent, Using Different Routes Of Administration; 1996-repository.uonbi.ac.ke:8080/xmlui/handle/123456789/26123
129. M Rupesh et al, Embelin ameliorates testosterone-induced hyperplasia in rats, Proceedings of the....Springer
130. Park N et al, Embelin-Induced Apoptosis of Human Prostate Cancer Cells Is Mediateed Through Modulation of Akt and β-Catenin Signaling, PLoS One 2015, Aug 7; 10(8): e0134760
131. Y Dai, Embelin enhances therapeutic efficacy of ionising radiation in prostate cancer,www.e-century.org/files/e_century_sample_ manuscript.pdf
132. Krishnaswamy and Purushothaman, Antifertility properties of Embelia ribes, Ind. J. Exp. Biol 1980; 1359-1360
133. E. O. Wango, Anti-fertility effects of embelin in female Sprague-Dawley rats may be due to suppression of ovarian function, Acta Biologica Hungarica, Volume 56, Issue 1-2, 2005
134. AO Prakash, 1992, Anti-implantation mechanism action of embelin in rats-Agris-FAO, agris.fao.org/agris-search/
135. Anand O Prakash, Short term toxicity of embelin in female rats, Phytotherapy Research, August 1994, Wiley Online Library
136. Bharat Lal and Neeraj Mishra, Importance of Embelia ribes: An Update, International Journal Pharmaceutical Sciences and Research, ICV 2015; 90.24
137. Reuter S et al, Embelin suppresses osteoclastogenesis induced by receptor activator NF- κB ligand and tumor cells in vitro through inhibition of the NF- κB cell signaling pathway, Molecular Cancer Research, 2010; 8: 1425-1436
138. Ahn K S et al, Embelin, an X chromosome-linked inhibitor of apoptosis protein, blocks nuclear factor-kappa-aB (NF- κaB) signaling pathway leading to suppression of NF- κaB-regulated antiapoptotic and metastatic gene products. Mol. Pharmacol 2007; 71: 209-219
139. W-J Lu, Mortalin-p53 interaction in cancer cells is stress dependent and constitutes a selective target for cancer therapy, Cell Death Differ. 2011 Jun; 18(6): 1046-1056
140. Nupur Nigam et al, Targeting Mortalin by Embelin Causes Activation of Tumor Suppressor p53 and Deactivation of Metastatic Signaling in Human Breast Cancer Cell, PLoS One, 2015; 10(9): e0138192
141. Embelin inhibits TNF-α converting enzyme and cancer cell metastasis: molecular dynamics and experimental evidence, BMC Cancer, 2014 Oct 22; 14: 775
142. Oliver Coutelle et at, Embelin inhibits endothelial mitochondrial respiration and impairs neoangiogenesis during tumor growth and wound healing, EMBO Molecular Medicine (2014) e201303016
143. Uday P. Kundap et al, Plant Derived Phytocompound, Embelin in CNS Disorders A Systemic Review, Front Pharmacol. 2017; 8:76
144. Sekar Mahendran et al, Synthesis and Evaluation of Analgesic and nti-inflammatory Activities of Most Active Free Radical Scavenging Derivatives of Embelin-A Structure-Activity Relationship, Chem. Pharm. Bull. 59(8): 913-919 (2011) August 2011
145. Rosalyn Pena et al, Domino Synthesis of Embelin Derivatives with Antibacterial Activity, Journal of Natural Products 2016, 79(4): pp 970-977
146. Usha Raina et al, Antibacterial Activity of Some Synthesized Metal Complexes of Embelin V. International Journal of Syntheses and Characterization 4(1), January-June 2011, pp 11-13
147. Ann Ngari, Embelin and Its Synthetic Derivatives, Evaluation Of Antibacterial Activities, Lambert Academic Publishing, 2013-12-28
148. Saba Maanvizhi, Preparation Characterization and antidiabetic efficacy of nanoparticles of Natural Benzoquinone and its Metal Complexes an Approach Under in vitro and in vivo Animal Model Studies, Shodhganga.inflibnet.ac.in; 9 May 2015
149. Durg S et al, Antidiabetic activity of Embelia ribes, embelin and its derivatives: A systematic review and meta-analysis, Biomed Pharmacother, 2017, Feb; 86: 195-204
150. Kantham Srinivas et al, Anti-mitotic activity of Embelin derivatives, International Journal of Phytopharmacology, 1(2), 2010, 98-103
151. Singh B et al, Synthesis and anti-proliferative activities of new derivatives of Embelin, Bioorg Med Chem Lett. 2014 oct 15; 24 (20): 4865-4870
152. Jianyong Chen et al, Design, Synthesis and Characterization of new embelin derivatives as potent inhibitors of X-linked inhibitor apoptosis protein Bioorganic and Medicinal Chemistry Letters, Volume 16, Issue 22, Nov 2006, Pages 5805-5808
155. Ospina LF et al, Inhibition of acute and chronic inflammatory responses by the hydroxybenzoquinonic derivative rapanone; PMID: 11745012
156. Luis Fernando Ospina, Inhibition of Acute and Chronic Inflammatory Responses by the Hydroxybenzoquinonic Derivative Rapanone, https://www.researchgate.net/publication/11611911
157. K de la Vega-Hernandez et al, Discerning the antioxidant mechanism of rapanone:A naturally occuring benzoquinone with iron complexing and radical scavenging activities, J Inorg Biochem 2017 May; 170:134-147
158. V. Shah et al, Chonemorphine and Rapanone-Antiparasitic Agents from Plant Sources, Journal of Natural Products, Volume 50, No 4, pp 730-731; Jul-Aug 1987
159. Calle J et al, Alteration in the reproduction of mice induced by rapanone, J Ethnopharmacol, 2000 Aug; 71(3): 521-525
160. Victor Kuete et al, Cytotoxicity of Plumbagin, Rapanone and 12 other naturally occuring Quinones from Kenyan Flora towards human carcinoma cells, BMC Pharmacology and Toxicology, 21 December 2016
161. Aiyar S N et al, Medicinal Plants of Asia-Pacific: Drugs for the Future?; Phytochem 3(2) 335-339 1963;
164. Balachandran et al, Synthesis and medicinal properties of plant-derived vilangin, International Information System for Agricultural Science and Technology 2014.
165. Bheemasankara Rao et al, Chemical Examination of Embelia ribes. I. Isolation of a new Constituent, "Vilangin",
166. R Narayanaswamy et al, Inhibition of Angiogenesis and nitric oxide synthase (NOS) by embelin and vilangin using in vitro, in vivo and in silico, Advanced Pharmaceutical Bulletin, 2014 December 31; 4(2): 543-548
168. C. Balachandran et al, Synthesis and medicinal properties of plant derived vilangin, Environmental Chemistry, September 2013, Volume 11, Issue 3, pp 303-308
169. Stalin A et al, Hypoglycemic activity of of 6-bromoembelin and vilangin in high-fat diet fed-streptozotocin-induced type 2 diabetic rats and molecular docking studies, Life Sci. 2016 May 15; 153:100-117
170. GU Harish et al, Endangered Medicinal Plant Embelia ribes Burm. f.-A Review, Pharmacognosy Journal, Volume 4, Issue 27 Jan-Feb 2012; www.phcogfirst.com
173. Zutshi U, Sharma SC, Kaul JL, Atal CK, Kinetic fate of potassium embelate, a non-narcotic centrally acting analgesic after oral and intravenous administration, Pharmacology, 1990; 40(3): 179-184.
174. Sanjesh G Rathi et al, Antifungal Activity of Embelia ribes Plant Extracts, DOAJ, January 2010, https://www.researchgate.net/50590004 (B)
175. N Radhakrishnan et al, Molecular docking studies of embelin (Simple natural benzoquinone) and its derivatives as a potent tyrosinase inhibitor, Journal of Chemical and Pharmaceutical Research, 2013, 5(10): 320-326 (C)
176. Laxmi C and Mishra 2003, https://books.google.co.in/books?isbn=084931366X
177. Atal CK et al, Non-narcotic orally effective, centrally acting analgesic from Ayurvedic drug, J Ethnopharmacol 1984 Aug; 11(3): 309-317
178. S. K. Dhar et al, Energy reserves of the brain during potassium embelate-induced antinociception in rat, Indian Journal of Physiology and Pharmacology October-December 1987
179. Zutshi U, Johri RK, Atal CK, Possible interaction of potassium embelate, a putative analgesic agent, with opiate receptors, Indian J Exp. Biol. 1989 July; 27(7): 656-657
180. Dr. K. M. Nadkarni's Indian Materia Medica 1994; https://books.google.co.in/books?isbn=8171541437
181. https://en.wikipedia.org/wiki/Caffeic_ acid
182. Ikeda K et al, Inhibition of multiplication of herpis simplex virus by caffeic acid, Int J Mol Med 2011; 28: 595-598
183. Kim JH et al, Antiangiogenic effect of caffeic acid on retinal neovascularization. Vascular Pharmacol 2009; 51: 262-267
184. Nardini et al, Inhibition of human low-density lipoprotein oxidation by caffeic acid and other hydroxycinnamic acid derivatives. Free Radic Biol Med 1995 Nov 19(5): 541-542
185. www.webmed.com/ingredientmono-1266-caffeic %20acid.aspx?
186. Prateek Sharma, Cinnamic acid derivatives: A new chapter of various pharmaceutical activities, J Chem. Pharm. Res., 2011, 3(2): 403-423
188. Ayano Itoh et al, Hepatoprotective Effect of Syringic acid and Vanillic Acid on Concanavalin A-induced Liver injury, Biological and Pharmaceutical Bulletin, Volume 32, (2009); Joly 18, 2017; No 7 Page 1215-1219
189. Cassia Calixto-Campos et al, Vanillic acid inhibits inflammatory pain by inhibiting neutrophil recruitment, oxidative stress, cytokine production and NFκB activation in mice, Journal of Natural Products, 2015, 78(8), pp1799-1808
190. Faiz Ul Amin et al Vanillic acid attenuates Aβ1-42-induced oxidative stress and coognitive function, Jan 2017 www.nature.com>scientific reports> articles
191. W. Brand-Williams et al, Use of free radical method to evaluate Antioxidant activity, Lebensm.-Wiss. u-Technol. 28. 25-30, 1995
192. MJR Vaquero et al, Antibacterial effect of phenolic compounds from different wines, Food control, February 2007, Volume 18, Issue 2, Pages 93-101 193. B.L. Dhananjaya et al, Anticoagulant effect of Naja naja venom 5'nucleotidase: Demonstration through the use of novel specific inhibitor, vanillic acid, Toxicon, 07 July 2006, 48(4): 411-421
194. Ponnian Stanely et al, Protective effect of vanillic acid on electrocardiogram, lipid peroxidation, antioxidants proinflammatory markers and histopathology in isoprenalin induced cardiotoxic rats, European Journal of Pharmacology, Volume 668, Issue 1-2, October 2011, pages 233-240
195. J. L. Anderton et al, Effect of Ethamivan (Vanillic acid Diethyamide) on the respiratory response of healthy young men to carbon dioxide, in the absence of hypoxia, Brit. J. Pharmacol. 1962, 19, 142-152
196. Kim SJ et al, The beneficial effect of vanillic acid on ulcerative colitis, Molecules, 2010 Oct 19, 15(10): 7208-7217
197. Wen-Chang Chang et al Protective effect of vanillic acid against hyperinsulinemia, hyperglycemia and hyperlipidemia via alleviating hepatic insulin resistance and inflammation in high fat-diet (HFD)-fed rats, Nutrients 2015, 7, 9946-9959
198. Huang SM et al, Inhibitory effect of vanillic acid on methylglyoxal-mediated glycation in apoptotic Neuro-2A Cells, Neurotoxicology, Volume 29, Issue 6, November 2008, Pages 1016-1022.
199. P Piyachaturawat et al, Enhancement of fertilization by piperine in hamsters, Cell Biol Int 21 (7): 405-409, 7 1997
201. Hwang SJ et al, Anti-inflammatory effects of chlorogenic acid in lipopolysaccharide-stimualted RAW 264.7 cells. Inflamm Res. 2014 Jan; 63(1): 81-90
202. Michel David dos Santos et al, Evaluation of the Anti-inflammatory, Analgesic and Antipyretic Activities of Natural Polyphenol Chlorogenic Acid, Biol. Pharm. Bull. 29(11) 2236-2240; (2006)
203. Ningjian Liang and David D. Kitts, Role of Chlorogenic Acids in Controlling Oxidaative and Inflammatory Stress Conditions, Nutrients, 2016 Jan; 8(1): 16
204. Aneela Maalic et al, Chlorogenic acid: A pharmacologically potent molecule, Acta Poloniae Pharmaceutica-Drug Research; Volume 73, No.4 pp. 851-854, 2016
205. Chen WC et al, Effect of topical application of chlorogenic acid on excision wound healing in rats, Planta Med. 2013 May; 79(8): 616-621
206. Sato Y et al, In vitro and in vivo antioxidant properties of chlorogenic and caffeic acid, International Journal of Pharmaceutics, Volume 403, Issues 1-2, 17 January 2011, Pages 136-138
207. Kim HR et al, Chlorogenic acid suppresses pulmonary eosinophilia, IgE production and Th-2 type cytokine production in an ovalbumin-induced allergic asthma: activation of STAT-6 and JNK is inhibited by chlorogenic acid, International Immunopharmacology, 2010 Oct; 10(10:1242-1248
208. HD Quin et al, Effect of chlorogenic acid on mast cell-dependent anaphylactic reaction, International Immunopharmacology, 2010 Sept; 10(9): 1135-1141
209. ZhaohuaLiua, Evaluation of chlorogenic acid using a ploliteal lymph node assay in BALB/c mice, Food and Chemical Toxicology; Volume 48, Issue 4, April 2010, Pages 1059-1065
210. Mingbao Lin et al, Evaluation of the Potential Sensitization of Chlorogenic Acid: A Meta-Analysis, Evidence-Based Complimentary and Alternative Medicine, Volume 2013, Article ID 208467, 9 pages.
211. Chan-Ho Lee et al, Chlorogenic Acid Attenuates High Mobility Group Box 1(HMGB 1) and Enhances Host Defense Mechanisms in Murine Sepsis, Mol. Med. 2012; 18(1): 1437-1448
212. Lou Z et al, Antibacterial activity and mechanism of action of chlorogenic acid, J Food Science 2011 August 76(6):M398-403
213. Mirna L et al, Antibacterial activity and Antifungal and Anti-Mitotoxigenic Activities Against Aspergillus flavus and A. ochraceus of Green Coffee Chlorogenic acids and Dodecyl Chlorogenates, Journalof Food Safety, 1st August 2013, Volume 33, Issue 3, pages 360-363
214. Ding Y et al, Antiviral activity of chlorogenic acid against influenza A (H1N1/H3N2) viruses and its inhibition of neuraminidase, Sci. Rep. 2017 Apr, 10:7:45723
215. Gui-Feng Wang et al, Anti-hepatitis activity of chlorogenic acid, quinic acid and caffeic acid in vivo and in vitro, Antiviral Res 2009Aug, 83(2) 186-190
216. Xiang Li et al, Chlorogenic acid inhibits the Replication and Viability of Enterovirus 71 in vitro, September 30, 2013, http://journals.plos.org/plosone
217. Woo Sang Sung et al, Antifungal action of chlorogenic acid against pathogenic fungi mediated by membrane disruption, Pure Appl. Chem., Vol.82, No. 1, pp 219-226, 2010
218. Mirna L et al, Antibacterial activity and Antifungal and Anti-Mitotoxigenic Activities Against Aspergillus flavus and A. ochraceus of Green Coffee Chlorogenic acids and Dodecyl Chlorogenates, Journalof Food Safety, 1st August 2013, Volume 33, Issue 3, pages 360-363
219. Khaled M et al, The Role of Chhlorogenic Acid Supplementation in Anemia and Mineral Disturbances Induced by 4-Tert-Octylphenol Toxicity , Journal of Dietary Supplements
220. Yang JS et al, Chlorogenic acid induces apoptotic cell death in U 937 leukemia cells through caspase-and mitochondria-dependent pathways, In Vivo, 2012 November-December; 26(6): 971-8
221. Mou-Tuan Huang et al, Inhibitory Effect of Curcumin,Chlorogenic Acid and Ferulic acid on Tumor Promotion in Mouse Skin by 12-O-tetradecanoylphorbol-13-acetate, Cancer Research, 48, 5941-4946, November 1, 1988
222. Rong Ping Zhou et al, Chlorogenic acid Prevents osteoporosis by Shp-2/PI3K/Akt Pathway in Ovariectomized Rats, PLOS: Decembe 29, 2016
223. Kelly L Johnston et al, Chlorogenic acid acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: glycemic effects of chlorogenic acid and caffeine 1'2'3, American J Clin Nutr.October 2003;78(4): 728-733
224. Marilena Kampa et al, Antiproliferative and apoptotic effects of selective phenolic acids on T47D human breast cancer cells: potential mechanisms of action, Breast Cancer Research 2003, 6:R63.
225. Farah A et al, Chlorogenic acid from green coffee extract are highly bioavailable in humans, J Nutr. 2008, December; 138(12):2309-2315
226. Lee K et al, Chlorogenic acid ameliorates brain damage and edema by inhibiting matrix metalloproteinase-2 and 9 in rat model of focal cerebral ischemia, Eur J Pharmacol. 2012 Aug 15; 689(1-3): 89-95
227. Heitman E et al, Cognitive and neuroprotective effects of chlorogenic acid, Nutr Neurosci 2017 Jan; 20(1):32-39
228. Shen W et al, Chlorogenic acid inhibits LPS-induced microglial activation and improves survival of dopaminergic neurones, Brain Res Bull. 2012 Aug 1; 88(5): 487-494.
229. Mani Neelakandan et al, (2017), Pharmacological effects of chlorogenic acid: an overview, Int. J. Res. Pharm. Sci. 8(1): 28-32
230. Hideyuki ITO et al, Chlorogenic Acid and Its Metabolite m-Counaric Acid Evoke Neutite Outgrowth in Hippocampal Neuronal Cells, Bioscience, Biotechnology, and Biochemistry, Volume 72, 2008- Issue 3
231. Hao ML et al, Therapeutic efficacy of chlorogenic acid on cadmium-induced oxidative neuropathy in a murine model, Exp.Ther. Med 2015 May; 9(5): 1887-1894
232. Fang SQ et al, Beneficial effects of chlorogenic acid on alcohol-induced damage in PC-12 cells, Biomed Pharmacother, 2016 Apr; 79: 254-62.
233. Anissa Belkaid et al, The chemopreventive properties of chlorogenic acid reveal a potential new role for the microsomal glucose-6-phosphate translocase in brain tumor progression, Cancer Cell Int. 2006 March 27; 6:7
234. Urgent R et al Heavy coffee consumption and plasma homocysteine: a randomized controlled trial in healthy volunteers Am J Clin Nutr, 2000
235. Olthof MR et al, Consumption of high doses of chlorogenic acid present in coffee or black tea increases plasma total homocysteine concentrations in humans, Am J Clin Nutr, 2001
236. Mesas AE et al, The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: a systematic review and meta-analysis. Am J Clin Nutr. 2011
237. Kozuma K et al, Antihypertensive effect of green coffee bean extract on mildly hypertensive subjects, Hypertens Res 2005
238. Suzuki A et al Green coffee bean extract and its metabolites have a hypotensive effect in spontaneously hypertensive rats, Hypertens Res. 2002
239. Suzuki et al, Chlorogenic acid attenuates hypertension and improves endothelial function in spontaneously hypertensive rats, Journal of Hypertension: June 2006, Volume 24, Issue 6, pp 1065-1073.
240. Yanyan LiaoSijun Dong et al, Flos Lonicerae Extracts and Chlorogenic Acid Protect Human Umbilical Vein Endothelial Cells from the Toxic Damage of Perfluorooctane Sulphonate, Inflammation, June 2013, Volume 36, Issue 3, PP 767-779
241. Onakpoya I J et al, The effect of chlorogenic acid on blood pressure: a systematic and meta-analysis of randomized clinical trials, J Hum Hypertens, 2015 Feb; 29(2): 77-81
242. Zhao Y et al, Antihypertensive effects and mechanisms of chlorogenic acids, Hypertens Res. 2012 Apr; 35(4):379-374
243. XuZhanga et al, Chlorogenic acid protects mice against lipopolysaccharide-induced acute lung injury, Injury, Volume 41, Issue 7, July 2010, Pages 746-752
244. Narita Y, Inhibitory activity of chlorogenic acids in decaffeinated green coffee beans against porcine pancreas lipase and effect and effect of a decaffeinated bean extract on an emulsion of olive oil, Biosci Biotechnol Biochem 2012, 76(12): 2329-31
245. Haito Shi et al, Chlorogenic acid reduces liver inflammation and fibrosis through inhibition of toll-like receptor 4 signaling pathway, Toxicology, Volume 303, 7 January 2013, Pages 107-114
246. Khaled M, Chlorogenic and Caffeic Acids in Liver Toxicity and Oxidative Stress Induced by Methamphetamine, Journal of Toxicology, Volume 2014, Article ID 583494
247. Nari Yun et al, Protective effects of of chlorogenic acid against ischemia/reperfusion injury in rat liver: molecular evidence of its antioxidant and anti-inflammatory properties, The Journal of Nutritional Biochemistry, Volume 23, Issue 10, October 2012, Pages 1249-1255
248. Kazumi Yagasaki et al, Inhibitory effects of chlorogenic acid and its related compounds on the invasion of cells in culture, Cytotechnology 33: 229-235, 2000
249. Yuan Yan et al, Chlorogenic acid enhances the effects of 5-fluouracil in human hepatocellular carcinoma cells through the inhibition of extracellular signal-regulated kinases, Anticancer Drugs, 2015, Jun; 26(5): 540-546
250. Stefanello N et al, Effects of chlorogenic acid, caffeine and coffee on behavioral and biochemical parameters of diabetic rats, Mol Cell Biochem, 2014 Mar; 388(1-2) 277-86
251. Stefanello N et al, Effects of chlorogenic acid, caffeine and coffee on components of purinergic system of streptozotocin-induced diabetic rats, J Nutr Biochem, 2016 Dec; 38: 145-153
252. MF Mcarthy, A chlorogenic acid-induced increase in GLP-1 production may mediate the impact of heavy coffee consumption on diabetes risk, Medical hypotheses, 2005, Elsevier
253. Khang Wei Ong et al, Antidiabetic and anti-lipidemic effects of chlorogenic acid are mediated by ampk activation, Biochemical Pharmacology, Volume 85, Issue 9, 1 May 2013, Pages 1341-1351
254. Krishnamoothy Karthikesan et al, Protective effect of tetrahydrocurcumin and chlorogenic acid against streptozotocin-nicotinamide generated oxidative stress-induceddiabetes, Journal of Functional Foods, Volume 2, Issue 2, April 2010, Pages 134-142
255. Shengxi Meng et al, Roles of Chlorogenic Acid on Regulating Glucose and Lipid Metabolism: A Review, Evidence-Based Complimentary and Alternative Medicine, Volume 2013, Article ID 801457, 11 Pages
256. Thom E, The effect of chlorogenic acid enriched coffee on glucose absorption in healthy volunteers and its effect on body mass when used long-term in overweight and obese people, J Int Med Res. 2007 Nov-Dec, 35(6): 900-8
257. Onakpoya I et al, The use of green coffee extract as a weight loss supplement: a systematic review and meta-analysis of randomised clinical trials, Gastroenterol Res Pract 2011; pii: 38852
258. Cho AS et al, Chlorogenic acid exhibits anti-obesity property and improves lipid metabolism in high-fat diet-induced obese mice, Food Chem Toxicol 2010 March; 48(3): 937-43
259. Li SY et al, Modulating effects of chlorogenic acid on lipids and glucosemetabolism and expression of hepatic peroxisome proliferator-activated receptor- in golden hamsters fed on high fat diet, Biomedical and Environmental Sciences: BES 01 April 2009, 22(2): 122-129
260. K. Karthikesan et al, Antihyperlipidemic effect of chlorogenic acid and tetrahydrocurcumin in rats subjected to diabetogenic agents, Chemico-Biological Interactions, Volume 188, Issue 3, 5 December 2010, Pages 643-650
261. Errol Zeiger, Toxicological Summary for chlorogenic acid and Caffeic acid, Review of Toxicological Literature, Triangle Park North Carolina 27709 July 1998
262. Estefania Burgos-Moron et al, The Coffee Constituent Chlorogenic Acid Induces Cellular DNA Damage and Formation of Topoisomerase I- and II- DNA Complexes in Cells, J. Agric. Food Chem., 2012, 60 (3): 7384-7391
263. Taylor Thurow's thesis, Effect of chlorogenic acid and neochlorogenic acid on human colon cancer cells, University of Arkansas April 2012.
264. Kang TY et al, The studies of chlorogenic acid antitumor mechanism by gene chip detection: the immune pathway gene expression, J Anal Methods Chem, 2013; 2013: 617243; Epub2013 May 9
265. Roushi Xu, Atnitumor Molecular Mechanism of Chlorogenic Acid on Inducing Genes GSK-3β and APC and Inhibiting Gene β-catenin, Journal of Analytical Methods in Chemistry, Volume 2013, Article ID 951319, Pages 7.
266. Olthof MR et al, Consumption of high doses of chlorogenic acid, presennt in coffee, or of black tea increases plasma total homocysteine concentrations in humans, Am J Clin Nutr, 2001 March; 73(3): 532-538
269. Y Oyama H et al, Cytotoxic effects of methanol, formaldehyde and formate on dissociated rat thymocytes: A possibility aspartame toxicity, Cell Biology and Toxicology, February 2002, 18:43
270. Yingrong Chen et al, Pharmacokinetics and bioavailability of cinnamic acid after oral administration of Ramulus cinnamomi in rats, https://www.researchgate.net/publication/26234600
271. Hadjipavlou-Litina D et al, Aryl-acetic and cinnamic acids as lipoxigenase inhibitors with antioxidant, anti-inflammatory and anticancer activity. Methods Mol Biol, 2015; 1208:361-377
272. Sova M et al, Antioxidant and antimicrobial activities of cinnamic acid derivatives, Mini Rev Med Chem, 2012 Jul; 12(8):
273. W Sun et al, Synthesis and properties of cinnamic acid series organic UV ray absorbents-interleaved layered double hydroxides, Materials Letters, 2007, 61, 1881-1884
274. N Fausta et al, Benzoic acid and cinnamic acid derivatives as antioxidants: Structure-activity relation, J Agric. Food Chem; 1999, 47, 1453-1459.
275. Sova M et al, Antioxidant and antimicrobial actiities of cinnamic acid derivatives, Mini Rev Med Chem, 2012 Jul; 12(8): 749-67
276. Guzman JD, Natural cinnamic acids, synthetic derivatives and hybrids with antimicrobial activity, Molecules, 2014 Nov 25; 19(12): 19292-349
277. Narasimhan B et al, Esters, amides and substituted derivatives of cinnamic acid: synthesis, antimicrobial activity and QSAR investigations, Eur J Med Chem,2004 Oct; 39(10): 827-834
278. Prateek Sharma, Cinnamic acid derivatives: A new chapter of various pharmaceutical activities, J Chem. Pharm. Res., 2011, 3(2): 403-423
279. Prateek Sharma, Cinnamic acid derivatives: A new chapter of various pharmaceutical activities, J Chem. Pharm. Res., 2011, 3(2): 403-423
280. Prateek Sharma, Cinnamic acid derivatives: A new chapter of various pharmaceutical activities, J Chem. Pharm. Res., 2011, 3(2): 403-423
281. Evandro Luis de Oliveira Niero et al, Cinnamic acid induces apoptotic cell death and cytoskeleton disruption in human melanoma cells, J Exp Clin Cancer Res. 2013 May; 32(1):21
282. MNA Rao, PN Raman, DR Kulkarni, 1987; Central nervous system depressant activity of cinnamic acid derivatives, www.ijpsonline.com
283. Surendra S. Parmar, J. P. Barthwal, Effect of cinnamic acid on potassium stimulated respiration in rat brain slices, Biochemical Pharmacology, 1966, Volume 15, Issue 11, November 1966, pages 1888-1890
284. Prateek Sharma, Cinnamic acid derivatives: A new chapter of various pharmaceutical activities, J Chem. Pharm. Res., 2011, 3(2): 403-423
285. Prateek Sharma, Cinnamic acid derivatives: A new chapter of various pharmaceutical activities, J Chem. Pharm. Res., 2011, 3(2): 403-423
286. Zhou XW et al, Synthesis of 6-cinnamoyl-2H-benzo[b][1,4]oxazin-3[4H]-ones and their effects on A549 lung cancer cell growth, Eur J Med Chem. 2014 May 22; 79:95-101
287. Bingyan Zhu et al, Inhibition of histone deacetylases by trans-cinnamic acid and its antitumor effect against colon cancer xenografts in athymic mice, Mol Med Rep. 2016 May; 13(5): 4159-4166
288. Reddy ND et al, In vitro and in vivo evaluation of novel cinnamyl sulfonamide hydroxamate derivative against colon adenocarcinoma, Chem Biol Interact. 2015 May 25; 233:81-94.
289. Nibal et al, Cinnamic acid activity towards Trichlorfon pesticide and liver function enzymes in rat, Magazine of Al-Kufa University for Biology; Vol. 6, No 1, Year 2014.
290. Nibal et al, Biochemical and Hepatoprotective Effects of Pure Cinnamic acid Against Cyclophosphamide in White Rats, http://www.iajs.net/iasj?func=fulltext&aId=60974
291. Amany A et al Cinnamic acid AttenuatesCisplatin-Induced Hepatotoxicity and Nephrotoxicity, Journal of Basic and Environmental Sciences, 3(2016)1-9
292. Nibal K et al, Liver histopathological of purification cinnamic acid activity against endoxan in mice, Journal of Genetic and Environmental Resources Conservation, 2014; 2(1): 22-29
293. Kais Mnafgui et al, Anti-obesity and cardioprotective effects of cinnamic acid in high fat diet-induced obese rats, J Food Sci Technol. 2015 Jul; 52(7): 4369-4377
294. Prateek Sharma, Cinnamic acid derivatives: A new chapter of various pharmaceutical activities, J Chem. Pharm. Res., 2011, 3(2): 403-423
295. Adisakwattana S et al, In vitro effects of cinnamic acid derivatives on protein tyrosine phosphatase 1B, J Enzyme Inhib Med Chem. 2013 Oct; 28(5): 1067-72
296. Lee S et al, Synthesis of cinnamic acid derivatives and their inhibitory effects on LDL-oxidation, aceyl-Co A: cholesterol acyltransferase-1 and-2 activity and decrease of HDL-particle size, Bioorg Med Chem Lett, 2004 Sep 20; 14(18):4677-4681
297. Prateek Sharma, Cinnamic acid derivatives: A new chapter of various pharmaceutical activities, J Chem. Pharm. Res., 2011, 3(2): 403-423
298. Yibchok-anun S et al, Insulin-secretagogue activity of p-methoxycinnamic acid in rats, perfused rat pancreas and pancreatic beta-cell line, Basic Clin Pharmacol Toxicol. 2008 May; 102(5): 476-482
299. Adisakwattana S et al, Insulin-releasing properties of a series of cinnamic acid derivatives in vitro and in vivo, J Agric Food Chem. 2008 Sep 10; 56(17): 7838-7844
300. Adisakwattana S et al, Mechanisms of p-methoxycinnamic acid-induced increase in insulin secretion, Horm Mrtab Res 2011 Oct; 43(11): 766-73
301. Adisakwattana S, Cinnamic acid and its Derivatives: Mechanisms for Prevention and Management of Diabetes and its Complications; Nutrients 2017 Feb 21; 9 (2).
302. Prabhakar PK et al, Interaction of cinnamic acid derivatives with commercial hypoglycemic drugs on 2-deoxyglucose uptake in 3T3-L1 adepocytes, J Agric Food Chem. 2011 Sep 28; 59(18): 9835-44
303. Chang HK et al, Stimulatory effect of cinnamic acid analogues on alpha 1A-adrenoceptors in-vitro, J Pharm Pharmacol 2003 Jun; 55(6): 833-837
304. De P et al, Cinnamic acid derivatives as anticancer agents-a review, Curr Med Chem. 2011; 18(18): 1672-703
305. Mielecki M et al, Cinnamic acid Derivatives as Inhibitors of Oncogenic Protein Kinases-structure, mechanisms and Biomedical Effects, Curr Med Chem. 2016; 23(10):954-82
306. Mielecki M et al, Analogues of cinnamic acid benzyl amide as nonclassical inhibitors of activated JAK2 kinase, Curr Cancer Drug Targets. 2014; 14(7): 638-651
307. Sova et al, Cinnamic acid derivatives induce cell cycle arrest in carcinoma cell lines. Med Chem 2013 Aug; 9(5): 633-641
308. Reddy ND et al, An appraisal of cinnamyl sulphonamide hydroxamate derivatives (HDAC inhibitors) for anti-cancer, anti-angiogenic and anti-metastatic activities in human cancer cells, Chem Biol Interact. 2016 Jun 25; 253:112-124
309. John A Hoskin, The occurrence, metabolism and toxicity of cinnamic acid and related compounds, Journal of Applied Toxicology December 1984
311. Bharat Lal and Neeraj Mishra, Importance of Embelia ribes: An update, International Journal of Pharmaceutical Sciences and Research, ICV (2015): 90.24
313. Jiang LH et al, Daucosterol promotes the proliferation of neural stem cells, J Steroid Biochem Mol Biol; 2014 Mar; 140:90-9